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The twin-arginine translocation (Tat) pathway is a robust protein translocation system 
capable of transporting cellular proteins across the bacterial cytoplasmic membrane.  
A hallmark of the bacterial Tat pathway is its ability to export proteins that have 
attained a fully-folded structure prior to export.  An inbuilt feature of the Tat system is 
a folding quality control (QC) mechanism that discriminates between 
unfolded/misfolded and correctly folded proteins, allowing only the latter to pass 
through the inner membrane.  This mechanism holds great promise for biotechnology 
applications because it has the potential to ensure the quality and structural integrity of 
exported proteins.  Yet, despite the significance of the Tat system, the precise 
mechanism by which the TatABC protein complex delivers folded proteins into the 
periplasm remains poorly understood.  Likewise, very little is known about the folding 
QC mechanism.  Studies from our laboratory suggest that the QC mechanism resides 
within the TatABC proteins.  Thus, to shed more light on this enigmatic process, we 
implemented a directed co-evolution strategy whereby all three components of the Tat 
pathway were evolved simultaneously to isolate suppressors that relaxed the QC 
feature.  Selection of suppressors was enabled by a genetic selection comprised of a 
poorly folded substrate protein (α3B) fused to the selectable reporter beta-lactamase 
(Bla).  By screening recombinant libraries of the tatABC operon, we were able to 
 isolate variants that exported previously translocation-incompetent substrates and non-
native Tat substrates.  The resulting TatABC variants represent putative suppressors of 
the QC mechanism.  Further information gained from these suppressors should 
provide a detailed understanding of the molecular mechanisms involved in TatABC-
mediated QC.  Moreover, these studies demonstrate that directed co-evolution of 
cellular protein machinery is a viable new strategy for dissecting complicated, poorly 
understood multiprotein complexes in living cells. 
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 CHAPTER 1 
 
INTRODUCTION TO THE TWIN-ARGININE TRANSLOCATION (TAT) 
PATHWAY IN ESCHERICHIA COLI AND GENERAL QUALITY CONTROL 
MECHANISMS WITHIN LIVING CELLS 
 
1.0 Introduction 
 In order for a protein to be functional, it must first fold properly within the cell.  
However, not all proteins fold the same way, i.e., proteins' native folds are remarkably 
variable.  For example, some proteins fold very easily and quickly without the need 
for additional assistance, while others require the coordination of a cofactor (1) or 
binding partner (2, 3), and still others require post-translational modifications such as 
disulfide bond formation (4) or glycosylation, to gain protein function.  A testament to 
the diversity and complexity of protein folding is the immense range of folding 
kinetics.  It is generally recognized that the speed of protein folding can vary over 
eight orders of magnitude, with the fastest known folder able to achieve its native 
structure within just a few hundred nanoseconds (5-7).  The birth of recombinant DNA 
technology has in many ways further exacerbated this fundamental protein folding 
problem in that many non-native, engineered proteins are required to fold properly in 
order to function in their new host, however, very little information can be predicted 
from their primary amino acid sequences alone.  Moreover, an ongoing challenge to 
this field is interpreting how single mutations will, and do, affect protein folding (5, 
8).  Despite this perplexing conundrum, all organisms have evolved mechanisms to 
assist in the process of protein folding, from chaperones to proteolysis and almost 
everything in between. 
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  The work presented herein will systematically address each of these aspects of 
protein folding quality control and proofreading, with an overall focus on the process 
of translocation of folded targets.  We will follow the general path that a nascent 
polypeptide would take within the cell, that is, we will first address accessory factors 
and molecular chaperones that aid in protein folding, followed by the translocation 
processes which deliver preproteins to their final destinations, and finally we will 
examine several protein degradation pathways which exist in order to cleanup 
misfolded or otherwise unusable protein substrates. 
 
1.1 General molecular chaperones that assist in the folding of nascent polypeptides  
 Quality control of the protein folding landscape begins with molecular 
chaperones within the cytoplasm of the cell and is a form of protein proofreading.  
Many molecular chaperones exist in organisms, from eukaryotes down to single 
cellular prokaryotes, and they all serve the same basic function – to assist nascent 
polypeptides in folding or to maintain them in an unfolded state.  This can be achieved 
in a variety of ways depending on the particular chaperone and the ultimate location to 
which the substrate is destined.  For example, the family of ribosome-associated 
chaperones, including but not limited to, trigger factor (TF) (9-11), heat-shock protein 
70 (Hsp70) (12), and prefoldin (13, 14), act by stabilizing the ever-elongating nascent 
polypeptides directly at the site of synthesis, i.e., on the ribosome (15).  Alternatively, 
chaperonin systems, such as DnaKJ/GrpE and GroEL/GroES, act in an ATP-
dependent manner to directly assist newly synthesized preproteins to fold in the 
cytoplasm.  While most nascent polypeptides (~65-80%) are thought to interact with 
trigger factor, a substantially smaller, but significant portion of proteins interact with 
DnaKJ (~10-20%) and even fewer with the GroEL/GroES (~10-15%) chaperonin 
system (15). 
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  As might be expected, the ribosome-associated factors are the first chaperones 
to interact with nascent chains.  For many small proteins that fold quickly on their 
own, this is the only assistance that they will receive during their lifetime.  However, 
many larger proteins require additional assistance from other chaperonin systems, such 
as the ones mentioned above.  While not all molecular chaperones have the same 
mechanism of action, in general, the heat-shock proteins, which are upregulated 
during periods of cellular stress, function to prevent protein aggregation by binding to 
exposed hydrophobic patches and unstructured backbone regions of their substrates – 
a hallmark of unfolded proteins (15-18).   
 Overall, there are many different molecular chaperones present within the cell 
of both prokaryotes and eukaryotes, all of which assist the cell in producing high 
quality, fully folded proteins in a well-orchestrated manner.  These systems mark the 
first form of protein quality control and are a fundamental aspect of maintaining cell 
viability through the production of folded and functional protein products. 
 
1.2 General protein secretion in bacteria 
 In bacteria, proteins are made by ribosomes in the cytoplasm and assisted by 
general molecular chaperones as described above, but not all proteins ultimately end 
up in the cytoplasm – some 20% are transported into the periplasmic space where they 
carry out their function (19).  Bacteria have evolved elegant protein secretion 
pathways that are responsible for delivering protein substrates to their final 
destination.  In general, there are two distinct pathways in Escherichia coli, the 
general secretory pathway (Sec) and the twin-arginine translocation pathway (Tat). 
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 1.2.1 The general secretory (Sec) pathway 
 As the name suggests, the general secretory (Sec) pathway is responsible for 
the transportation of most secreted proteins across the cytoplasmic inner membrane in 
gram-negative bacteria, and across the cytoplasmic membrane and cell wall in gram-
positive bacteria.  Substrates targeted to this pathway are recognized by short (~20-30 
amino acids in length) characteristic leader peptides known as Sec signal sequences.  
These sequences consist of three distinct domains:  1) a N-region that is largely basic 
in nature; 2) a hydrophobic domain of ~7-13 residues, termed the H-region; and 3) a 
slightly charged section known as the C-region (20, 21).  With the exception of the 
above mentioned characteristics, these signal sequences are relatively similar to each 
other and lack many additional distinguishing features.  Despite their generality, these 
short, cleavable (22) N-terminal extensions serve a very important function and are 
largely responsible for determining the final location of a protein. 
 In bacteria, nascent polypeptides synthesized with a N-terminal Sec signal 
sequence are detected by the ATPase motor protein, SecA (23).  It was long thought 
that the Sec pathway was characterized by posttranslational translocation initiated by 
the pathway-specific molecular chaperone, SecB (24), while cotranslational 
translocation was achieved by the signal recognition particle (SRP) (25).  However, 
recent studies have clearly demonstrated that SecA interacts with the ribosomal 
protein L23, at a location close to the polypeptide exit tunnel, suggesting that SecA 
could interact with its substrate during translation, i.e., in a cotranslational manner, in 
order to facilitate the efficient channeling of Sec substrates to this "posttranslational" 
pathway (26).  Regardless of the specific molecular interactions of SecA, all current 
models of the general secretory pathway agree that Sec substrates are held in an 
unfolded confirmation and directed to the Sec translocase.  This translocase consists of 
the three integral membrane proteins, SecY, SecE, and SecG, which form a complex 
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 with a very narrow opening of only ~5-8Å in diameter that serves as the channel in 
which translocation can occur (27).  The SecA molecule, a highly conserved and 
essential molecular motor, subsequently drives protein translocation through this very 
narrow pore in an unfolded confirmation through successive rounds of ATP hydrolysis 
(28-31).  Only after the preprotein is present in the periplasmic space is it allowed to 
fold and achieve its final native confirmation. 
 Alternatively, while still utilizing the same SecYEG translocon, the signal 
recognition particle can also export proteins in an unfolded confirmation.  This is 
achieved by immediately binding the nascent chain at the ribosomal exit tunnel (32) 
and directing the entire complex to the translocase, whereby the nascent chain is 
simultaneously exported as it is being translated, i.e., "cotranslational" translocation 
(33).  It is important to note that the SRP pathway has a great deal of overlap with the 
Sec pathway, and even shares some of the same machinery.  Furthermore, the 
common theme of this protein secretion pathway is that the substrate is maintained in 
an unfolded state, exported, and only allowed to fold after translocation has occurred. 
 
1.2.2 The twin-arginine translocation (Tat) pathway 
 While the vast majority of secreted proteins in Escherichia coli are exported 
via the general secretory (Sec) pathway, approximately six percent (34) still exit the 
cytoplasm through a completely different system discovered approximately ten years 
ago.  The hallmark of this fundamentally unique conduit, termed the twin-arginine 
translocation (Tat) pathway, named after its signature (S/T)RRxFLK signal peptide 
motif (3, 35-37), is its ability to allow only natively folded proteins passage across the 
cytoplasmic bacterial membrane, all the while maintaining delicate membrane 
integrity (2, 38-41).  This is in stark contrast to both the SRP and Sec pathways, which 
only transport unfolded substrates. 
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  The Tat pathway was first discovered in plant chloroplast thylakoid 
membranes as a ΔpH-dependent protein import system (42, 43).  Since then, 
analogous protein export pathways have been identified in both bacteria and archaea.  
Interestingly, the Tat pathway also has been recently implicated in the pathogenicity of 
many bacterial pathogens, e.g., Agrobacterium tumefaciens (44), Escherichia coli 
O:157 (45, 46), Legionella pneumophila (47, 48), and both Pseudomonas aeruginosa 
(49) and syringae (50).  As a likely result of the potentially horrifying consequences to 
human health, there have been great strides in the past  several years to better 
understand the nuances of this pathway. 
 In gram-negative bacteria, the Tat machinery consists of three membrane-
bound proteins: TatA (paralogue TatE), TatB, and TatC.  While TatA, TatB, and TatE 
form single transmembrane α-helices, followed by another short, cytoplasmic helix at 
their C-termini, TatC is structurally much more complex, consisting of six 
transmembrane α-helices (51-56).  Furthermore, deletion of any of these proteins will 
partially (in the case of TatA or TatE alone) or completely (in the case of TatB, TatC, 
or TatA and TatE together) block export of Tat-dependent substrates (37, 57-59), 
giving rise to a variety of characteristic phenotypes, e.g., formation of long 
filamentous chains and membrane defects (60). 
 The current working model of Tat translocation suggests that the substrate 
protein may be directly inserted into the lipid membrane as the initial step (61, 62), 
followed by an interaction with a receptor complex, consisting of the essential 
proteins, TatB and TatC (57, 58).  Regardless of how membrane insertion occurs, the 
TatBC pre-complex then associates with the homo-oligomeric TatA complex, forming 
a transient TatABC translocase, which is responsible for exporting the natively folded 
substrates into the periplasm (63, 64).  However, the precise mechanism in which it is 
able to perform this feat is unknown.  One possibility is that the TatA homo-
6 
 oligomeric complex forms a ring structure around the substrate, allowing transport of 
the folded substrate to occur through its pore.  While several single-particle imaging 
studies have documented the formation of a double ring-like structure with Tat-
specific substrates bound (65, 66), these studies fail to adequately describe how the 
Tat translocase can accommodate such a vast array of diameters due to the export of 
native substrates ranging from ~10-140kDa in size (3).  Alternatively, a second 
possibility was proposed whereby the TatA homo-oligomeric complex would act to 
locally destabilize the membrane, allowing for substrates to be subsequently pulled 
through it (67, 68).  Regardless of which method, if either is correct, in contrast to the 
ATP-dependent Sec pathway, the export of Tat substrates is known to occur by the 
proton motive force characteristic of charged membranes (69), whereby the energy 
needed to drive export is acquired solely by the exchange of protons.  Once the 
substrate is in the periplasm, the Tat signal sequence is cleaved by signal peptidase I 
and the mature protein is released, marking the end of its journey. 
 Due to the distinct virulence role of the Tat pathway (70), elucidating the 
molecular mechanisms driving this system have been a significant focus of many 
research studies with the goal of developing potential downstream biotechnological 
applications, e.g., broad-spectrum antibiotics.  However, much more interesting is the 
idea of actually harnessing the pathway's exceptional ability to transport only folded 
proteins, and subsequently, engineering novel protein architectures that have passed 
through this cellular pre-screen.  Several examples of this have already come to 
fruition, such as, the engineering of robust single-chain variable fragment (scFvs) 
antibodies (71) and enhancing the solubility of aggregation-prone substrates (72).  
Nevertheless, understanding the intrinsic mechanisms that drive this quality control 
will truly be the key to unlocking the most rewarding downstream engineering 
applications. 
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 1.2.3 Quality control along the Tat pathway in Escherichia coli 
 The mere notion that folded proteins are exported via the Tat machinery, while 
unfolded or otherwise misfolded substrates are not, suggests the presence of some 
form of quality control (QC).  However, there currently exists very little evidence 
about the molecular mechanism by which the Tat system is able to perform this most 
remarkable task.  According to the above mentioned model of Tat export, it is 
conceivable that quality control could occur at any of these stages. 
 While some studies have shown accessory factors involved in substrate 
proofreading in a chaperonin-like manner (73-76), these studies are substantially less 
interesting due to obvious similarities with the Sec pathway and general molecular 
chaperones.  In particular, we previously discussed a general class of broad-acting 
molecular chaperones with very little substrate specificity.  In addition to these 
promiscuous chaperones, there also exists many substrate-specific chaperones unique 
to particular protein translocation pathways, and even, to individual protein substrates.  
The more general of these chaperones are typically found in the general secretory 
pathway, such as SecA and SecB.  Conversely, the twin-arginine translocation 
pathway has a number of cytoplasmic chaperones, such as, DmsD and TorD (74, 77), 
which bind only a few unique substrates.  While these chaperones are largely substrate 
specific, they function in much the same way as general chaperones in that they bind 
to the unique Tat signal sequence of their cognate substrates, sequester them away 
from the Sec machinery, assist them in folding, and ultimately direct them to the Tat 
translocon (78). 
 Nevertheless, a growing body of biochemical studies (79, 80), suggest that the 
TatB and TatC proteins form a receptor complex early in the translocation process, 
with which both folded and misfolded Tat substrates interact and potentially facilitate 
Tat-mediated folding quality control.  Furthermore, additional biochemical studies 
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 have shown that the TatBC complex, specifically the N-terminus of TatC, acts to 
initially recognize the signature Tat signal sequence (81-83), suggesting that the Tat 
machinery itself indeed has a pivotal quality control responsibility early on in the 
translocation process.  Moreover, it has been recently shown in vitro that the Tat-
competent substrate, oxidized ssTorA-PhoA, cross-linked to the TatBC complex (81) 
in a completely different manner as compared to its Tat-incompetent form (i.e., 
reduced), suggesting that the Tat machinery was capable of discerning the folding 
state of the substrate (80).  Interestingly, it also has been recently shown that the Tat 
apparatus initiates degradation of misassembled FeS protein substrates, as evidenced 
by NrfC/NapG degradation in wild type strains but accumulation in either tat null 
strains or Tat-misdirected strains (84), providing further indication of its innate 
proofreading capabilities. 
 Taken together, the fact that both transport-competent and transport-
incompetent substrates are targeted to the Tat translocase, yet only passage of properly 
folded/assembled substrates is allowed, strongly favors the hypothesis that Tat-
mediated folding quality control is a function of the machinery components 
themselves.  Therefore, the true merit of these studies lies in the fact that no other 
system in biology uses the export machinery itself in proofreading and quality control, 
and thus it would distinguish the Tat machinery as a unique example in all of biology.  
Hence, the research conducted herein will focus on the elucidation of the molecular 
mechanisms responsible for this putative inbuilt quality control feature. 
 
1.3 Protein degradation pathways in Escherichia coli 
 An inevitable byproduct of protein folding, is protein misfolding.  As such, 
organisms have necessarily evolved machinery components capable of breaking down 
malformed, dysfunctional proteins into their constituent elements, i.e., amino acids, 
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for reuse. These degradation systems are the final form of quality control within the 
cell, whereby misfolded, aggregated, or otherwise unusable protein is rapidly degraded 
by precise molecular machines, cleared away to reduce clutter within the cell, and 
ultimately recycled.   
 In bacteria, several examples of these degradation systems include, but are not 
limited to, FtsH, Lon and the Clp degradation machinery (85, 86).  In the context of 
exported proteins, it is also noteworthy to mention the periplasmic protease, DegP, 
which is likewise responsible for degrading misfolded periplasmic proteins (87, 88).  
Interestingly, proteases largely act via a similar mechanism as molecular chaperones, 
in that, they recognize solvent exposed hydrophobicity in misfolded substrates, bind 
them, and subsequently perform their natural function – in this case proteolysis (89).  
Therefore, while proteases function as a general housekeeping mechanism within the 
cell, they are still extremely important in maintaining overall quality control along the 
protein folding landscape. 
 In summary, we have discussed a variety of protein folding quality control 
mechanisms present within the cellular environment.  These systems range from 
accessory factors participating early on in the translation process and assisting newly 
synthesized proteins to fold, to protein secretion pathways, and ultimately to 
degradation pathways invoked upon protein misfolding.  The most interesting of these 
processes, i.e., Tat-mediated folding quality control, will be discussed further in the 
remaining chapters. 
 
 CHAPTER 2 
 
EXPLOITING THE INBUILT FOLDING QUALITY CONTROL MECHANISM OF 
THE TAT MACHINERY PROTEINS TO DISCRIMINATE BETWEEN FOLDED 
AND MISFOLDED SUBSTRATES 
  
2.0 Introduction 
 While a variety of studies have demonstrated that the Tat system can 
discriminate between folded and misfolded substrates (38, 71, 72, 90), there remains 
to be a study that has developed such a system capable of decoupling the terms 
“unfolded” and “unstable/insoluble,” due to the inclination of the majority of 
misfolded proteins to form insoluble precipitates and/or become rapidly targeted for 
degradation.  Thus, the pursuit for the ideal target substrate that will allow for a 
thorough dissection of the Tat pathway’s proofreading and quality control mechanisms 
remains a coveted prize.  Recently, we have found such a target with the de novo 
designed three helical bundle proteins, termed α3A, α3B, α3C, and α3D (91, 92). 
 The benefit of using this family of proteins as a model substrate-set lies in the 
very nature of de novo design.  With significant advances in the field of bioinformatics 
and the ever expanding power of computational analyses, the world of computer-based 
algorithms has given birth to the field of de novo protein design (93, 94).  De novo 
design embodies the idea of customizing a functional protein of distinct structure from 
scratch.  Several recent studies have successfully created generic, quantitative 
computational algorithms based on protein structure determining physicochemical 
properties (95), enabling the de novo rational design of simple proteins with well-
ordered secondary and tertiary structures (91, 93, 96, 97).  Moreover, a myriad of 
structurally important features have been computationally predicted, and subsequently 
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 created, including functional metal-binding pockets (98, 99), zinc fingers (100-102), 
coiled coils (103), and a variety of additional small protein domains (104-107).  As 
such, it becomes possible to create and utilize native-like small proteins of minimally 
sufficient secondary and tertiary structure catered to a specific need. 
 To this end, we selected the highly thermostable α3D protein because it 
perfectly fills our need for a well-characterized and well-ordered model protein of 
clear directed evolutionary lineage.  This thermostable three helical bundle originates 
from a similarly de novo designed antiparallel three-stranded coiled-coil, termed Coil-
Ser (108). The α3D variant is the culmination of multiple, iterative rounds of design, 
each resulting in a more evolved species.  In particular, the final ordered, thermostable 
structure was achieved through the addition of helical capping boxes (109, 110), 
rearrangement of select residues allowing for stabilizing electrostatic interactions to 
occur (111), and the repacking of the hydrophobic core with a diversified set of amino 
acids (112).   α3D was shown to display thermodynamic and spectroscopic properties 
typical of native proteins, validating the de novo prediction and design.  The precise 
modifications at each step that produced each successive α3 protein are enumerated in 
Table 2.1 below as determined by (91, 92). 
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  These three helical bundle proteins are aligned below to show the similarities 
in their primary sequences and the rationally designed modifications made between 
each iterative round of design (Figure 2.1a and Table 2.1).  Moreover, the NMR 
solution structure of the most thermodynamically stable variant, α3D, was solved (92) 
to confirm the desired tertiary structure that was designed de novo (Figure 2b&c). 
 
 
 
Figure 2.1 Primary and tertiary structures of the α3 proteins.  (a) Primary 
sequence alignment of the de novo designed three helical bundle proteins, α3A, α3B, 
α3C, and α3D – all rationally designed from the same parental Coil Ser de novo 
protein.  Predicted helices are drawn above the primary sequences at the appropriate 
locations.  (b)  Three-dimensional solution structure of α3D (PBD ID: 2a3d) as 
determined by Walsh et al. (1999) (92), displaying the repacked core of hydrophobic 
sidechains shaded dark gray. 
 
 Taken together, the highly thermostable α3D and its less evolved precursor α3’s 
of the same family provide a perfect continuum of folded structure, ranging from 
molten globules (α3A and α3B) to well-ordered three helical bundles (α3C and α3D).  
onsequently, herein we report the use of this well-characterized family of proteins to C
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 genetically dissect the quality control feature inherent in the Tat pathway with much 
greater resolution than was previously possible. 
 
2.1 α3 de novo proteins as a Tat-mediated screen for folding 
As a fortuitous side effect of the quest for a rationally designed, well-ordered, 
3 3
ism of the twin-arginine translocation 
ince all α3 variants are soluble at comparable levels, we were able to 
3 
3 variant nominally uniform, 
 
three-helical bundle, with native-like folding character, DeGrado and coworkers 
created a family of de novo proteins with progressively increasing order and structure 
(91, 92).  Furthermore, despite varying degrees of folding, all four variants remained 
cytoplasmically soluble and could be detected by immunoblotting.  Thus, these de 
novo designed proteins, termed α A through α D, became the perfect tool for 
interrogating the putative quality control mechan
pathway.  S
exploit their differential thermal stabilities in an effort to develop a functional screen 
of substrate folding character, effectively decoupling “soluble” from “folded” for the 
first time.  This feat was accomplished by expanding on the pSALect-based selection 
for protein solubility described by Fisher et al. as a tool to correlate the cell growth on 
selective media with the solubility of a target protein (72). 
 In particular, the DNA sequence encoding each α protein substrate was 
optimized for E. coli expression and cloned into the pSALect vector – in between a N-
terminal TorA signal sequence (ssTorA) and a C-terminal TEM-1 β-lactamase reporter 
– to create a tripartite fusion protein (113).  Under the control of the lac-promoter, the 
translated protein fusion is directed to the Tat machinery due to the TorA signal 
sequence, and if folded, exported across the inner membrane and into the periplasm 
where the C-terminal TEM-1 β-lactamase fusion partner can hydrolyze β-lactam ring 
derived antibiotics, such as ampicillin or carbenicillin, conferring resistance to said 
antibiotics.  Therefore, with the solubility levels of each α
14 
 using ampicillin as a selective marker, protein substrates may be screened for folding 
character alone as indicated by cellular resistance to ampicillin – the greater the 
resistance, the better folded the substrate protein. 
 In an effort to develop this system into a functional screen for substrate folding 
character, constructs pSALect–α3A, B, C, and D in a wild-type MC4100 strain 
background were serial diluted and spotted onto LB-agar plates supplemented with 
200μg/ml of ampicillin and allowed to grow overnight at 30oC.  Strikingly, cells 
harboring the α3D substrate grew out to a dilution of 10-6, whereas, identical cells 
carrying the α3A variant only grew to a dilution of 10-1.  In agreement with their 
respective de novo structures, cells with the α3B and α3C variants grew to intermediate 
dilution factors (Figure 2.2a, left panels), suggesting that rationally designed proteins 
of varying order and stability can be differentially exported via the Tat pathway.  
e β-l
 However, with these findings alone, it is still uncertain as to whether the Tat 
machinery itself is responsible for this quality control.  If it is so, this would be the 
first of its kind in biology and an incredible avenue for engineering recombinant 
proteins produced through the Tat pathway.  To begin probing the answer to this 
question, tatC knockout cells (58) were transformed with the same pSALect–ssTorA–
α3–TEM1 fusions and spotted on ampicillin containing LB-agar plates.  TatC is an 
essential component of Tat-mediated translocation, and thus, tatC knockouts will 
completely abolish transport through this pathway (58).  Therefore, if this growth 
phenotype is truly a product of Tat quality control, these ΔtatC cells will not transport 
th actamase fusions and will not grow on selective media.  Indeed, the growth 
phenotype was abolished in ΔtatC cells harboring any variant of the α3–β-lactamase 
fusions (Figure 2.2a, right panels), suggesting that this observation is in fact a result of 
a tat-specific phenomenon. 
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Figure 2.2 Genetic demonstration of the inbuilt folding quality control 
mechanism of the Tat machinery proteins. Establishment of a robust genetic screen 
for Tat-mediated quality control.  (a) As indicated, cells containing each protein-fusion 
were serial diluted and spotted onto plates containing either 25 μg/ml chloramphenicol 
or 200μg/mL ampicillin, respectively.  Wild-type MC4100 cells, harboring an intact 
Tat pathway differentially export the protein-fusion, consistent with the folded state of 
the target α3 protein.  Conversely, B1LK0 cells (ΔtatC), deficient in Tat export, show 
a marked deficiency in growth, demonstrating Tat-mediated exclusivity.  (b) Western 
blot analysis of cytoplasmic and periplasmic fractions prepared from wild-type 
MC4100 cells (left) and ΔtatC B1LK0 cells (right) by the ice-cold osmotic shock 
protocol and blotted against α-Bla (mouse monoclonal 1ºα-Bla diluted 1:100 and goat 
α-mouse-HRP diluted 1:2,500), demonstrating the localization of the protein-fusion in 
the cytoplasm for the molten globular target α3s and in the periplasm for their ordered 
counterparts.  Consistent with a Tat-specific housecleaning mechanism, all protein-
usions in the ΔtatC strain are almost entirely degraded due to the genomic deficiency 
 Tat export.  
f
in
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  In conjunction with the β-lactamase spot plate screen, subcellular fractions 
were prepared via the ice-cold osmotic shock procedure (38), followed by Western 
blot analysis in order to confirm the presence of soluble substrate in the periplasm of 
transport-competent cells.  Trimethylamine N-oxide reductase (TorA) is an exclusive 
Tat substrate (38) limiting the export of β-lactamase to the Tat pathway in the form of 
a fusion partner to the α3 protein substrates.  Therefore, β-lactamase will only be 
present in the periplasm if its fusion partner, i.e. α3A, B, C, or D, is properly folded 
and competent for transport.  As expected, the presence of β-lactamase was detected in 
the periplasm for the α3C and α3D substrates and in the cytoplasm for the molten 
globular cases of α3A and α3B (Figure 2.2b), corroborating the de novo design work of 
DeGrado et al. (91, 92) and the protein solubility selection of Fisher et al. (72).  
Furthermore, in agreement with the current knowledge-base of Tat research, there was 
little to no detectable protein in either the cytoplasm or the periplasm in a ΔtatC strain 
background.  It has been observed by a variety of scholars that an active 
“housecleaning” mechanism associated with the Tat pathway rapidly degrades 
transport-incompetent substrates (38, 72, 114), and thus, it is no surprise that all 
variants are no longer detectable in this strain background. 
 
2.2 Discussion 
 In this study we have developed a genetic means of decoupling unfolded 
substrates from insoluble substrates, by utilizing a family of de novo designed proteins 
of increasing order, but comparable soluble expression.  In doing so, we have also 
demonstrated that it is the Tat machinery proteins themselves responsible for 
discriminating between folded and misfolded substrates.  As mentioned earlier, the 
true scientific merit of this study lies in the fact that no other system in biology enrolls 
the participation of the export machinery itself in proofreading and quality control, and 
17 
 thus, the evidence presented in this study acts as the first direct experimental evidence 
supporting these claims.  Furthermore, from an engineering perspective, the research 
described in this chapter has focused on first understanding this unique and complex 
system on a basic science level in order to eventually exploit the intrinsic folding 
quality control feature of the Tat pathway, as will be described in the remaining 
chapters. 
 Due to its potential to ensure the quality and structural integrity of exported 
proteins, elucidating the molecular mechanisms driving this system hold significant 
promise for the development of downstream biotechnological applications, e.g., 
engineering recombinant antibodies.  However, a major obstacle in the development 
process has been the lack of quality genetic screens aimed at understanding this Tat-
based quality control.  Thus, it is of paramount importance to develop an elegant 
genetic selection capable of screening recombinant libraries.  With advances in error-
prone PCR, a library selection is a convenient, high throughput method to explore the 
functional diversity of a vast sequence space of a desired gene or gene cluster, thereby 
exhausting an immense number of possible amino acid sequences responsible for 
specific gene functions.  As such, the goal of the work presented in this chapter was to 
y the foundation for the eventual development of a robust genetic selection of Tat-
 control that will ultimately be capable of screening large recombinant 
rarie
la
mediated quality
lib s of the tatABC operon in order to isolate broad-spectrum mutants suppressing 
Tat quality control.  The details of such a genetic selection will be presented in the 
following chapter. 
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 2.3 Materials and methods 
2.3.1 Bacterial strains, plasmids and growth conditions 
 MC4100 (F- ΔlacU169 araD139 rpsL150 relA1 ptsF rbs flbB5301) (115) 
served as the parental E. coli strain for all experiments conducted in this study.  An 
isogenic tatC knockout strain, B1LK0, was also used as indicated.  All genes encoding 
the α3 family of proteins were codon optimized for expression in E. coli and cloned 
into the protein-solubility selection plasmid, pSALect, using the NdeI and SpeI 
restriction enzyme sites as described (72, 113, 116).  Below is a full list of all strains 
and plasmids used in this study.  All plasmids generated in this study were confirmed 
by sequencing. 
 
 
 
2.3.2 Spot plating and growth studies 
 Spot plating was performed as previously described (72, 116).  Briefly, 
MC4100 or B1LK0 cells harboring a pSALect–ssTorA–α3–TEM1 plasmid were 
grown overnight at 37ºC in Luria Bertani (LB) medium supplemented with 25 μg/ml 
19 
 20 
red microliters of cells were removed from each culture, 
ted by factors of ten in a 96-
itional 90 min in fresh medium at 37ºC until an optical density of 
D600 ~0.5 was reached, at which time the cultures were induced with 1.0 mM IPTG 
and transferred to a 30ºC incubator.  For pSALect-based substrates, protein expression 
proceeded at 30ºC overnight for approximately 16.5 hours, at which time the cultures 
were pelleted via centrifugation for 15 min at 4ºC and 3,500 rpm.  Cell pellets were 
subsequently fractionated according to the ice-cold osmotic shock method as 
described elsewhere (38).  Induction conditions were performed in this manner to 
remain consistent with spot plate growth experiments.  Proteins were separated on a 
12% polyacrylamide gel (Bio-Rad) by SDS-PAGE and detected by Western blotting 
also as previously described (117, 118).  Protein detection was determined with the 
following primary antibodies:  mouse monoclonal 1ºα-Bla (Abcam) diluted 1:100 and 
rabbit polyclonal 1ºα-GroEL (Abcam) diluted 1:10,000. The following secondary 
α-mouse-HRP (Promega) diluted 1:2,500 
ed 1:2,500. 
chloramphenicol.  One hund
resuspended in fresh medium, and subsequently serial dilu
well tissue culture plate.  Five microliters of each sample were spotted onto ampicillin 
containing LB-agar plates until all samples at all dilutions were accounted.  Spot 
plates were incubated overnight at 30ºC for approximately 16.5 hours. 
 
2.3.3 Subcellular fractionation and Western blot analysis 
 Overnight cultures were prepared as described above.  The following day, 
overnight cells were subcultured ten-fold in LB containing antibiotics and allowed to 
grow for an add
O
antibodies were used as appropriate: goat 
and goat α-rabbit-HRP (Promega) dilut
 CHAPTER 3 
 
DEVELOPMENT OF A GENETIC SELECTION FOR THE ISOLATION OF 
MUTANT TRANSLOCASES SUPPRESSING QUALITY CONTROL 
  
3.0 Introduction 
ly folded substrates across 
d have this ability. 
 As such, it is of great interest to help elucidate the initial quality control steps 
along the Tat pathway, and especially, to determine the extent to which the Tat 
machinery itself undertakes this role.  Furthermore, given the nature of the transport 
 The unique ability of the Tat pathway to transport on
the bacterial inner membrane has sparked a vicious debate as to precisely how it is 
able to discern folded from misfolded.  There are generally two distinct possibilities 
that have arisen in response to early observations (38) suggesting that the Tat pathway 
processes both folded and misfolded substrates, but transports only the former.  The 
first possibility is the existence of one, or many, accessory factor(s) that perform a 
chaperonin-like function, binding to and sequestering substrates away from the 
machinery until they have achieved a threshold fitness to be exported (73, 74, 79, 
119).  Alternatively, a much more interesting possibility is that the Tat machinery 
proteins, i.e., TatA, TatB, and TatC, themselves are responsible for such scrutiny, 
granting transport approval for those deemed fit enough to pass quality control and 
rejecting those that are unfit for passage (38).  While first hypothesized in the seminal 
work by DeLisa and coworkers, there remains to be any direct, incontrovertible 
genetic evidence in live bacterial cells suggesting that this latter possibility is in fact 
the case.  Despite the lack of genetic evidence, there are several biochemical studies 
demonstrating that both folded and misfolded substrates do seem to interact with the 
Tat proteins, and thus, suggest that they could indee
21 
 phenomenon, which minimally inv tinct components that all seem to 
interact together (i.e. TatB, TatC, and the substrate), it is particularly prudent to 
und  is 
entirely ed for 
binding, recognition, and/or transport of a substrate through the Tat pathway.  
evidence suggests that not only the TatABC complex (82), but also 
erely
olves three dis
ertake this feat in an unbiased manner, akin to library selection.  Specifically, it
 possible that conformational changes of both TatB and TatC are requir
Moreover, recent 
m  the TatBC complex undergoes dramatic conformational changes upon 
substrate binding (120, 121), further bolstering the need for a tatABC library as 
opposed to simply a tatBC or tatC library.  Accordingly, screening a randomly 
mutated library of the entire tatABC gene cluster would provide the perfect avenue to 
investigate suppressor mutations, allowing for the isolation of clones with 
compensatory mutations, that is, two or more mutations that interact with each other, 
restoring a potentially adverse effect of only a single mutation (122).  This is in part 
the rationale for co-evolution studies aimed at evolving a particular enzyme in the 
context of how it interacts in its native environment. 
 Taken together, a genetic study linking changes in the actual genetic code to 
differential Tat-mediated export would serve at the ideal evidence needed to support 
the quality control hypothesis.  To this end, we sought to create a randomized library 
of mutant tat translocons and select for clones that would relax this putative inbuilt 
quality control feature, and doing so, would provide the first concrete genetic evidence 
directly linking the Tat machinery proteins to folding quality control. 
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 3.1 Isolation of a broad class of mutant TatABC translocases capable of suppressing 
quality control 
 As a preliminary, yet crucial, step toward the development of a tatABC library 
was the verification of the characteristic growth phenotype and selective periplasmic 
export of α3 substrate chimeras from a tatABC plasmid expressed construct.  To this 
end, pTatABC was constructed from a pBR322 vector.  In particular, the entire 
tatABC operon, which encodes the single polycistronic mRNA strand giving rise to the 
TatABC proteins (37), was cloned into the pBR322 backbone in place of the 
ampicillin resistance marker, resulting in only a tetracycline resistance cassette.  Next, 
DADE (MC4100 ΔtatABCD ΔtatE) cells (123) were co-transformed with both the 
pTatABC (harboring the tatABC gene cluster) construct and each pSALect–ssTorA–
α3–TEM1 partner plasmid, followed by spot plating on ampicillin selective media and 
Western blot analysis of its subcellular components.  Indeed, plasmid expressed 
TatABC proteins produced the same characteristic phenotype (Figure 3.1a, leftmost 
panel) as genomic TatABC, albeit at a greater ampicillin concentration.  However, this 
is not uncommon due to the differences in copy number and expression between 
genomic- and plasmid-based sources.  Furthermore, the identical transport 
phenomenon was observed via Western blotting (Figure 3.1b leftmost panel), 
confirming the functionality of the plasmid encoded TatABC machinery and providing 
an adequate template for randomized mutagenesis. 
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Figure 3.1 Isolation of class I and class II suppressor translocases based on 
growth on ampicillin and Western blot export of the α3 substrates.  A counter-
screen of mutant translocases reveals suppressors of either the α3B–TEM1 fusion 
alone or both α3A– and α3B–TEM1 fusions.  The top five suppressor mutants were 
transformed into DADE (ΔtatABCDE) cells harboring each of the pSALect–ssTorA–
α3–TEM1 plasmids, respectively, serial diluted by factors of ten, spotted onto 
suppressors, comprised of mutants 51, 57 and 66, were capable of transporting the 
least ordered, molten globular α3A protein-fusion.  Conversely, class II suppressors, 
namely mut 68 and mut 73, were only capable of exporting the selected molten 
globular substrate fusion, α3B–TEM1.  Analysis of α3 export was based on both 
growth on selective media (a) and Western blot analysis of subcellular fractions (b). 
Western blots characteristic of each suppressor class are shown and were performed as 
 
 Error-prone PCR (124) was used to generat
 
500μg/mL ampicillin containing plates, and incubated overnight at 30ºC.  Class I 
described in the Materials and methods section.   
e a random tatABC library of ~5.5 
x 106 members with an average random error rate of 2.0 nucleotides per gene.  The 
library was transformed into DADE (ΔtatABCDE) cells already harboring the 
pSALect–ssTorA–α3B–TEM1 plasmid and selected on an ampicillin concentration of 
200 μg/ml.  The α3B molten globular substrate was chosen due to its lack of export, 
localization in the cytoplasm, and ability to remain soluble without an inclination to 
aggregate (91).   
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  Thirty randomly chosen clones were isolated, cured of their pSALect plasmid, 
back-transformed into fresh DADE (ΔtatABCDE) cells containing the pSALect–
ssTorA–α3B–TEM1 plasmid, counter-spot-screened on 500μg/ml of ampicillin and 
rank-ordered according to their ability to grow on ampicillin selective media.  There 
were a variety of growth patterns for all of these mutants with more than ten growing 
out to a dilution factor of 10-6, similar to that of the well-ordered, native-like three-
helical bundle, α3D.  The top five growers were further characterized to determine the 
extent of suppression.  In particular, each pTatABC mutant was freshly co-
transformed into DADE (ΔtatABCDE) with each α3–TEM1 fusion encoded on the 
pSALect plasmid and spotted onto ampicillin selective plates (Figure 3.1a). 
ese class I suppressors have very different mutations in all three genes, confirming 
 
Strikingly, three of these five mutants, mut 51, mut 57, and mut 66 (hereafter referred 
to as class I suppressors) were even capable of transporting the aggregation prone, 
molten globular α3A–TEM1 fusion (Figure 3.1a, leftmost panels), suggesting that 
these are indeed genuine suppressors of quality control and that the Tat machinery is 
in fact performing this suppression such that translocation of previously transport-
incompetent substrates can occur.  To our knowledge, this is the first direct genetic 
evidence linking mutations in the Tat machinery to altered export of substrate proteins 
based solely on their folding character.  Equally interesting is the fact that all three of 
th
the hypothesis of necessary compensatory mutations enabling functionality (122).  
Conversely, mut 68 and mut 73, comprising a second class of best putative 
suppressors (hereafter referred to as class II suppressors), were fully capable of 
exporting the selected fusion substrate, α3B–TEM1, as determined by growth out to a 
dilution factor of 10-6 on 500μg/ml of ampicillin; however, they were unable to 
tolerate the less-ordered molten globular fusion, α3A–TEM1 (Figure 3.1a, rightmost 
two panels). 
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  Although we have previously shown in an MC4100 parental strain background 
that growth on ampicillin plates directly correlated with subcellular localization of the 
target substrate, the first question we asked of the top five growers post-selection was 
whether the substrate fusion could also be detected in the appropriate subcellular 
compartments.  Indeed, all mature α3–TEM1 fusions were found localized in the 
periplasm for the class I suppressors, while only α3B, C, and D were exported into the 
periplasm for the class II suppressors (Figure 3.1b).  From a wild-type translocase to 
class I and class II suppressors, the growth phenotype seen on ampicillin containing 
plates directly correlated with the Western blot localization of the substrate. 
 
3.2 Discussion 
 In this study we have utilized the genetic means of decoupling "unfolded" from 
"insoluble" substrates developed in Chapter 2 to screen a randomly mutated tatABC 
library containing ~5.5 x 106 members and directly select mutants allowing growth at 
a concentration that previously caused total cellular death.  The ability to grow on 
higher ampicillin concentrations alone does not necessarily indicate that these clones 
have suppressed quality control.  Rather, it merely demonstrates that the mutations 
introduced into the machinery components have allowed for more TEM-1 fusion to 
reside in the periplasmic space.  This could occur one of three ways.  First, the 
mutations could result in a hyperactive translocase that grows at higher ampicillin 
concentrations simply because it is able to export the substrate at a faster rate.  Second, 
the mutants could have somehow destabilized the membrane integrity, allowing every 
substrate passage across the inner membrane.  Third, the mutations could result in 
genuine suppressors of quality control.  That is, our original hypothesis would be 
validated.  However, if either scenario 1 or scenario 2 were the case, it would be 
unlikely that the substrates would be exported at levels comparable to a wild-type 
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 tr ase as determined by the Western blot analysis conducted within this chapter.  
Instead, one or both of the following two observations would be expected, but were 
not observed:  1) the mutants would export a much larger quantity of substrate protein 
into the periplasm due to their new hypersecreting ability; and 2) cytoplasmic 
chaperones, such as GroEL or DnaKJ, would leak into the periplasmic fraction due to 
the aforementioned membrane defects. 
 Given the evidence presented in this chapter, the third alternative is the most 
promising option and will be extensively explored in the following chapter as there are 
a number of questions still remaining that would validate this result.  For
ansloc
 example, 
veral interesting questions that would aid in the classification of these mutants and 
tion of authentic quality control suppression would be as follows:  
se
overall confirma
How do the mutants behave in the context of native Tat substrates?  How do the 
mutants respond to other non-native Tat substrates, those simply re-directed to the Tat 
pathway, or those presumably misfolded due to re-routing?  Are there growth defects 
as compared to wild-type Tat machinery strains?  Do the mutants retain some form of 
QC, or has all semblance of quality control been abolished?  In other words, has 
quality control been truly suppressed, or completely eliminated? 
 Taken together, this study provides the first direct genetic evidence suggesting 
that the Tat machinery components themselves indeed possess an inbuilt folding 
quality control mechanism.  While the precise molecular nuances responsible for this 
suppression still remain elusive, the development of a quality genetic selection capable 
of isolating mutants with relaxed folding quality control holds great promise for the 
future elucidation of these molecular details. 
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 3.3 Materials and methods 
3.3.1 Bacterial strains, plasmids, and growth conditions 
 MC4100's isogenic tat null strain, DADE (ΔtatABCDE) served as the parental 
E. coli strain for all experiments conducted in this study.  The parental plasmid-
encoded Tat machinery template was created by PCR amplification of the entire 
tatABC operon from MC4100 and cloned into the pBR322 backbone in place of the 
picilam lin resistance marker, resulting in a vector with only a tetracycline resistance 
cassette.  More specifically, the tatABC operon and its native promoter were ligated 
into pBR322 using the restriction sites AhdI and PvuI, resulting in the pTatABC 
vector.  This vector was subsequently used to create all downstream mutant variations 
used in the genetic selection described below in detail.  Below is a full list of all 
strains and plasmids used in this study.  All plasmids generated in this study were 
confirmed by sequencing. 
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 3.3.2 Library construction and selection 
ranslocases was constructed 
ty for selections and plated on a series of ampicillin 
oncentrations.  Plates were incubated overnight at 30oC, at which time individual 
clones were picked from the 200μg/mL plate and incubated in liquid culture. 
 
3.3.3 Plasmid curing and isolation of mutant tat vectors 
 The pSALect–ssTorA–α3B–TEM1 plasmid was cured from each clone by 
culturing the strain in the absence of chloramphenicol for several generations, 
streaking these cultures on LB-agar plates containing only tetracycline at an elevated 
temperature of 42oC for 24 hours, and subsequent overnight liquid culture of single 
colonies at 37oC.  All strains cured of the pSALect vector were unable to grow in LB 
supplemented with chloramphenicol, but retained growth in LB containing 
tetracycline, indicating the loss of the pSALect vector and continued possession of the 
id DNA isolated from these cured strains were 
 The library used for the isolation of suppressor t
using a modified procedure as described elsewhere (71, 116).  Briefly,  error-prone 
PCR was used to generate a tatABC library of ~5.5 x 106 members in the pTatABC 
vector.  Following construction, the plasmid library was transformed into ElectroMAX 
DH5α (Invitrogen) for library propagation and storage.  The plasmid library was 
midiprepped from this DH5α host and used to transform electrocompetent DADE 
(ΔtatABCDE) cells already harboring the pSALect–ssTorA–α3B–TEM1 partner 
plasmid.  Transformed cells were plated in serial dilutions and cultured overnight in 
500 mL of LB medium containing 10 μg/mL tetracycline, 25 μg/mL chloramphenicol, 
and .2% glucose.  The following day, plates were counted to ensure the diversity of 
the library was maintained, whereas, the overnight liquid culture was diluted to the 
appropriate cellular densi
c
mutated pTatABC vector.  Plasm
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 30 
(ΔtatABCDE) cells for all downstream backtransformed into empty DADE 
experiments. 
 
3.3.4 Spot plating and growth studies 
 Growth conditions and spot plating procedures used in this study are as 
described in Chapter 2.3.2, unless otherwise mentioned. 
 
3.3.5 Subcellular fractionation and Western blot analysis 
 Similarly, the methods for protein analysis by subcellular fractionation and 
Western blotting that were used in this study are as described in Chapter 2.3.3, unless 
otherwise mentioned. 
 CHAPTER 4 
 
HARACTERIZATION OF CLASS I AND CLASS II MUTANT TRANSLOCASES 
BROAD-ACTING SUPPRESSORS 
With the discovery of the Tat pathway occurring only recently, there is still 
ortant independent studies 
of these previous works, including the fidelity of the genetic 
reporter, the functionality of isolated "suppressor" mutants, and an overall lack of 
confirmatory evidence that such suppressor translocases interacted with defective and 
wild-type signal peptides. 
 Similarly, there have been a number of biochemical studies demonstrating 
preliminary evidence of distinct interactions between preproteins and the Tat 
machinery; however, the reliability of these interactions is frequently called into 
question due to the artificial environment in which the experiments are invariably 
performed.  The most promising in vitro studies have utilized a reconstituted Tat 
export system in the form of inverted inner membrane vesicles (80, 127).  While these 
are certainly a step in the right direction, there remains to be a quality genetic means 
of directly assaying these interactions. 
 Previous attempts to genetically link quality control to the Tat machinery by 
isolating suppressor mutants has largely failed primarily due to the lack of a quality 
genetic screen or selection.  For example, Kreutzenbeck et al. developed a genetic 
reporter system using the non-native Tat substrate ssTorA(KQ)-MBP and reported the 
C
AND VERIFICATION OF 
  
4.0 Introduction 
 
much to be learned about how it functions.  Several imp
have emerged (81, 125, 126) suggesting that the TatBC complex serves as the initial 
receptor binding site for precursor recognition.  However, numerous shortcomings 
were evident in each 
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 successful isolation of suppressor tra  a relaxed signal peptide specificity 
(126).  Despite these claims, their actual d ggested only a very limited ability to 
handicap in to a wild-
type translocase and wild-type –RR– signal peptide.  Moreover, in the development of 
ild-type translocase was fully able to export a defective twin-lysine 
he cytoplasm by the ClpXP protein degradation system as a 
raction, there remains to be the successful 
nslocases with
ata su
tolerate defective Tat signal peptides with merely one mutant having a marked 
 managing this defective signal peptide – 44% export compared 
their system, a w
signal peptide (126), suggesting that the screen was not as sensitive as they were 
claiming.  Furthermore, this mutant was able to export about 25% more protein with a 
wild-type –RR– signal sequence, implying that the mutant may actually be 
hypersecreting all substrates and not actually relaxing quality control. 
 A second study created a randomized library of only the tatC gene and 
screened it for increased fluorescence on the FACS using the substrate ssTorA(KK)-
GFP-SsrA, a substrate previously shown to result in a blockage of export, followed by 
immediate degradation in t
consequence of the SsrA tag (125).  However, a major drawback of this work was the 
isolation of suppressors which had lost their ability to export native Tat substrates, 
suggesting that the directed evolution strategy that was used resulted in a shift in 
functionality rather than an expansion of functionality.  Furthermore, similar to the 
work of Kreutzenbeck et al. (126), all of the suppressors reported in this work were 
only weak suppressors with at most a 20% improvement in function. 
 Thus, while attempts have been made to validate the early biochemical studies 
showing Tat-mediated substrate inte
development of a high-quality genetic means of corroborating these early observations 
and a lack of direct genetic evidence.  The work presented herein attempts to provide 
that missing element by thoroughly analyzing the best suppressors of folding quality 
control that were isolated from our genetic selection described in Chapters 2 and 3.  
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 By using a family of proteins all derived from the same parental platform, all with 
comparable expression levels, we believe that our system exceeds previous attempts in 
that it is able to discern the export fitness of a target substrate based solely on the 
degree of folding character, offering the first direct genetic evidence of Tat-mediated 
folding quality control.  Furthermore, while the best suppressors are able to export a 
number of previously transport-incompetent substrates, they otherwise retain all native 
functionality tested, as will be described in this chapter, indicating that they are indeed 
genuine suppressors of folding quality control. 
 
4.1 Native functionality of class I suppressors 
 One of the major concerns in several of the previous studies on suppressor 
mutants was the inability of the isolated suppressors to transport native Tat substrates. 
It is well-known that E. coli cells lacking a functional Tat export pathway are unable 
to transport the N-acetylmuramoyl-L-alanine amidases, AmiA and AmiC, responsible 
for cleavage of the N-acetylmuramic acid in peptidoglycan (125, 128-130).  This 
deficiency results in a cell's inability to properly divide during cell division and gives 
rise to a characteristic chain-like phenotype.  As such, plasmid DNA from each mutant 
clone was separately purified and back-transformed into DADE (ΔtatABCDE) cells 
lacking any other plasmid in order to test for complementation of the chain phenotype.  
All mutants showed full complementation of the chain phenotyp
 
e (Figure 4.1a), 
suggesting that each class I suppressor retained its native Tat functionality. 
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Figure 4.1 Class I suppressor export analysis of native Tat substrates. (a) Phase-
contrast micrographs demonstrating the complementation of the chain phenotype 
characteristic of tat null strains.  DADE (ΔtatABCDE) cells harboring functional Tat 
machinery show a wild-type singlet phenotype; whereas, empty DADE (ΔtatABCDE) 
specific amidases, AmiA and AmiC.  All suppressor mutants complemented this chain 
phenotype, including class I and class II suppressors.  (b)  Western blot analysis of two 
native Tat substrates, CueO and SufI, along with the popular non-native substrate, 
ssTorA-GFP, revealed export tolerance among all class I suppressors.  CueO and SufI 
were probed with mouse monoclonal 1ºα-Flag M2-HRP diluted 1:3,000 and GFP was 
probed with rabbit polyclonal 1ºα-GFP-HRP diluted 1:25,000. (c)  Fl
cells have a characteristic chain phenotype due to the inability to export the Tat-
uorescence 
microscopy of the ssTorA-GFP construct demonstrated polar accumulation of green 
fluorescence as characteristic of Tat-mediated GFP export. 
 
 In addition to the amidases, we interrogated two model Tat substrates, CueO 
(YacK) and SufI (FtsP).  While both proteins belong to the multicopper oxidase 
superfamily, SufI lacks the incorporation of metal cofactors (131), whereas CueO is 
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 typically found bound to four copper atoms (132).  Despite their affiliation with the 
same multicopper oxidase superfamily, these two quintessential Tat proteins have two 
disparate functions.  CueO is thought to maintain the copper levels within the cell and 
thus act as a resistance mechanism to copper toxicity (133).  However, SufI's putative 
function was only recently hypothesized to involve a structural role at the septal ring 
during cellular division (131).  Regardless of function, both substrates are exclusive to 
the Tat pathway and serve as vital components for interrogating native export 
functionality of Tat translocases.  Therefore, each class I suppressor was co-
transformed with native CueO and SufI expressed from a pBAD33 vector (134), 
induced for several hours, and fractionated via the ice-cold osmotic shock procedure in 
order to determine the subcellular localization of these model Tat substrates.  Indeed, 
both CueO and SufI were found at comparable levels in the periplasm of each class I 
suppressor as compared to a wild-type Tat translocase, suggesting native export 
functionality was retained (Figure 4.1b). 
y inactive in the periplasm 
ue to its inability to fold in the periplasm when exported via the general secretory 
 
4.2 Class I suppressors possess non-native export functionality 
 In an effort to explore the true extent of each class I suppressor's native export 
functionality, we began to interrogate non-native Tat substrates.  Green fluorescence 
protein (GFP) has been previously used as a robust substrate for measuring green 
fluorescence in E. coli and many other hosts.  Despite its popular use as a reporter 
protein, it was not until 2000 that Feilmeier et al. demonstrated that GFP is inactive in 
the periplasmic space.  More specifically, GFP is completel
d
pathway (135); however, it remains fully folded and active in the periplasm when 
exported through the twin-arginine translocation pathway (136, 137).  Interestingly, 
ssTorA-GFP is also at a minimum predominantly, if not exclusively, exported via the 
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 Tat pathway.  Therefore, ssTorA-GFP serves as the foundation for interrogating the 
ability of class I suppressors to export non-native Tat substrates.   Comparable to a 
wild-type translocase, each class I suppressor was found to export this non-native Tat 
fusion into the periplasm at a level of approximately 50% of the total soluble protein 
as evidenced by Western blotting (Figure 4.1b, rightmost panel).  Furthermore, a 
necessary component of Tat-mediated export is to determine whether the exported 
protein is folded, and therefore, is functional.  In agreement with earlier studies (136, 
138, 139), fluorescence microscopy of each class I suppressor revealed halo-like or 
polar sequestration of green fluorescence, indicative of fully folded, and functional 
periplasmic GFP (Figure 4.1c). 
 The archetypal non-native Tat substrate, ssTorA-PhoA, has previously set the 
bar as the defining substrate for quality control.  With the need for disulfide bond 
formation (140) and a native tertiary structure of a homodimer (141, 142), PhoA 
requires delicate assembly in a unique folding environment in order to achieve a native 
ld.  Furthermore, by replacing its native Sec leader peptide with a Tat signal fo
sequence, it was shown to become an exclusive Tat substrate (38).  For this reason, the 
ssTorA-PhoA fusion was used in the seminal quality control study, whereby DeLisa 
and coworkers first posited the existence of an intrinsic quality control mechanism 
resident in the actual Tat machinery proteins.  They demonstrated that the inability of 
Tat-mediated alkaline phosphotase export was likely a result of the highly reducing 
nature of the bacterial cytoplasm (38).  It is well known that the thioredoxin and 
glutaredoxin pathways naturally maintain the bacterial cytoplasm in a highly reducing 
state – an environment which strongly disfavors the formation of disulfide bonds (4).  
Thus, such proteins, required to fold in the cytoplasm, would be unable to properly 
fold prior to export via the Tat pathway.  Indeed, upon toggling the redox state of the 
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 cytoplasm to an oxidizing environment, export of ssTorA-PhoA was achieved, 
confirming the aforementioned hypothesis. 
 Accordingly, the benchmark for class I suppressors was established as the 
ability to allow export of this delicate substrate.  Remarkably, all three class I 
suppressors overcame the redox-induced lack of folding, allowing Tat-mediated 
translocation of the previously transport-incompetent reduced-PhoA as depicted by 
Western blot analysis of the subcellular fractions (Figure 4.2a).  Furthermore, 
compared to a wild-type translocase, each class I suppressor also allowed a greater 
accumulation of the preprotein in the cytoplasm – a hallmark of transport-competent 
substrates.  However, immunoblotting alone does not demonstrate that the alkaline 
phosphotase present in the periplasm is also functional, or whether it was exported in a 
inactive globular form.  Consequently, these same DADE (ΔtatABCDE)  cells were 
spread on plates supplemented with 0.1 mM isopropyl-β-D-thiogalactoside inducer 
(IPTG) and 150μg/mL 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in order to test 
the functionality of the periplasmic PhoA.  BCIP is a synthetic, chromogenic substrate 
of alkaline phosphotase which causes bacterial colonies to change from a white hue to 
a rich shade of blue in the presence of functionality active, periplasmic alkaline 
phosphotase and has been used to identify functional, Tat-mediated alkaline 
phosphotase activity (117).  Indeed, all three class I suppressors not only showed 
export of ssTorA-PhoA, but also changed a blue colony color, confirming the presence 
of folded and functionality active periplasmic PhoA (Figure 4.2b).  Likewise, in 
agreement with these previous studies, DADE (ΔtatABCDE) cells harboring a wild-
type translocase remained white. 
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Figure 4.2 Alkaline phosphotase as a benchmark for class I suppressors.  (a) 
DADE (ΔtatABCDE) cells harboring plasmid-encoded wild-type Tat machinery will 
not export Tat-directed PhoA as
blotting of class I suppressors revea
 evidenced by Western blot.  Conversely, Western 
ls localization of ssTorA-PhoA into the periplasm.  
All samples were probed with rabbit polyclonal 1ºα-PhoA-HRP diluted 1:5,000.  (b) 
Furthermore, due to the export of folded and functional alkaline phosphotase, class I 
suppressors form blue colonies on LB-agar plates supplemented with appropriate 
antibiotics, 0.1 mM isopropyl-β-D-thiogalactoside (IPTG) and 150μg/mL 5-bromo-4-
chloro-3-indolyl phosphate (BCIP). 
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 4.3 Genetic dissection of class I suppressors reveals the underlying residues 
responsible for the suppressor phenotype 
 Plasmid DNA from the best ten mutants was isolated and sequenced to 
determine the location of each mutation in the tatABC gene cluster (Table 4.1).  Most 
notably, 7 of 10 clones contained at least a single amino acid substitution at positions 
ranging from 94-99 of TatC, followed by at least one additional mutation in TatA 
and/or TatB.  This area of clustering is of particular interest because it is in the first 
putative cytoplasmic loop of TatC (52), and thus, would very likely be an area to first 
interact with a substrate in order to judge folding character. 
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  Furthermore, this grouping of mutants consists of 4 mutations at F94, a site 
previously identified as essential for Tat export (52, 125).  Due to the growing body of 
evidence suggesting TatC is a crucial component of this recognition and proofreading 
feature, our primary focus has been on TatC mutations, although, interesting mutations 
were eventually revealed elsewhere (Figure 4.3). 
 
 
Figure 4.3 Schematic of TatC mutations from the best ten suppressors overlaid 
on a TatC topology map.  The predicted topological structure of TatC as determined 
by Buchanan et al. (52), Behrendt et al. (143), and Ki et al. (54) was used to 
approximate the location of each TatC mutation pulled from the genetic selection.  
Based on these models, TatC is predicted to form six transmembrane α-helices with
two cytoplasmic, and three periplasmic loops as depicted above.  The bacterial 
cytoplasmic membrane is represented in the diagram by the uniformly shaded gray 
bar, with the cytoplasmic space shown below and the periplasmic space shown above.  
Strikingly, the majority of mutations are localized to the cytoplasmic domains, 
consistent with the hypothesis of Tat-mediated quality control. 
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  Each class I suppressor was analyzed to determine the minimal suppressing 
residues (MSR) accountable for the class I export phenotype.  Specifically, two 
restriction enzyme sites were introduced into the pTatABC plasmid by site-directed 
mutagenesis.  With a restriction enzyme site now flanking each tat gene, the new 
vector, hereafter named pTatABC-XX, was used to systematically replace a mutated 
t gene from each class I suppressor with its corresponding wild-type partner genes.  
For example, mutant 51 harbors two mutations in the tatC gene, namely P97S and 
A133T, along with N119S in tatB and K82T in tatA.  Therefore, pTatABC* was 
created by PCR amplifying only the mutated tatC gene and pairing it with the wild-
type versions of tatA and tatB to reveal a new variant harboring only the two tatC 
mutations, P97S and A133T.  This same procedure was repeated to create mutants of 
each singly mutated tat gene and the two combinations, tatAB and tatBC, producing 
five new mutant translocases for each selected suppressor.  All fifteen variants were 
co-transformed with the full panel of pSALect–ssTorA–α3–TEM1 fusions and spot 
plated on varying concentrations of ampicillin in order to determine the MSR for each 
class I suppressor (Figure 4.4).  As expected the MSR for both mutant 51 and 57 were 
found in the TatBC proteins, with mutant 51 allowing further simplification down to 
merely two residues within TatC.  Strikingly, the MSR for mutant 66 was narrowed
ta
 
down to a pair of glycine-to-serine mutations (G2S and G3S) in TatA.  These twin-
serines are even more perplexing in that they are located in the periplasmic domain of 
TatA. Nevertheless, they are indeed the residues responsible for conferring 
suppression of the quality control feature for mutant 66. 
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Figure 4.4 Genetic dissection of all class I suppressors at the single gene level.  All 
spotted in an identical manner as the class I selected mutants described above.  The 
Interestingly, one of the best ten suppressors, mutant 73, was comprised of a 
single mutation in each of the three tat genes, allowing for a unique opportunity to 
dissect the contributions of not only each gene, but of each individual mutation 
(Figure 4.5).  Ultimately, the MSR was identified as the contributions of not a single 
cells in this study were a DADE (ΔtatABCDE) strain background harboring a mutant 
copy of the pTatABC plasmid and one of each of the pSALect–ssTorA–α3–TEM1 
plasmids, as indicated.  Each class I suppressor was serial diluted by factors of ten, 
spotted onto 300 μg/mL ampicillin containing plates, and incubated overnight at 30ºC.  
Class I suppressors (leftmost panels), comprised of mutants 51, 57 and 66 were 
capable of transporting the least ordered, molten globular α3A protein-fusion.  As 
mentioned in the Materials and methods section, each selected translocase was 
subsequently genetically dissected by pairing a mutant gene with wild-type copies of 
the remaining tat counterparts.   These new variants, tatA*BC (second column from 
the left), tat(AB)*C (third column from the left), tatAB*C (third column from the 
right), tatABC* (second column from the right), or tatA(BC)* (rightmost panels) were 
following dissected mutants were also capable of transporting the least ordered, 
molten globular α3A protein-fusion, indicating that they were minimally necessary for 
suppression:   pTatABC*-Mut51, pTatA(BC)*-Mut57, and pTatA*BC-Mut66.  Genes 
marked with a * represent the mutant allele. 
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 mutation, but rather, the interaction of two mutations, one in TatB and one in TatC.  
This observation further validates the hypothesis that the intrinsic quality control 
feature of the Tat machinery resides within the TatBC multiprotein pre-complex.  
Remarkably, both single mutations (A98S in TatB and F94L in TatC) result in a loss 
of function, i.e., completely abolished export of all four α3–TEM1 fusions.  Thus, it is 
only the synergistic effect of both the A98S mutation in TatB and the F94L mutation 
in TatC that result in a reversal of function, allowing for suppression to occur.  Once 
again, this underlines the benefit of using a directed co-evolution approach in order to 
facilitate the isolation of genuine suppressors that naturally function as a multiprotein 
complex. 
 
 
 
Figure 4.5 Genetic dissection of a class II suppressor at single amino acid 
substitution resolution.  All cells in this study were a DADE (ΔtatABCDE) strain 
background harboring a mutant copy of the pTatABC plasmid and one of each of the 
pSALect–ssTorA–α3–TEM1 plasmids, as indicated.  Mutant 73, was identified as a 
class II suppressor by its ability to export only the α3B protein-fusion and its well-
ordered counterparts.  Furthermore, this mutant was sequenced to reveal only a single 
amino acid substitution in each tat gene.  Cells carrying the selected mutant 73 
translocase were serial diluted by factors of ten, spotted onto 300 μg/mL ampicillin 
containing plates, and incubated overnight at 30ºC (leftmost panels). In a similar 
fashion as previously described, this t ar nslocase was subsequently genetically 
dissected by pairing a mutant gene with wild-type copies of the remaining tat 
(third column from the left), tatAB*C (third column from the right), tatABC* (second 
counterparts.   These new variants, tatA*BC (second column from the left), tat(AB)*C 
column from the right), or tatA(BC)* (rightmost panels) were spotted in an identical 
manner as previously described.  Only the combination of mutant tatB and tatC 
together, but not individually, were capable of transporting at least the α3B protein-
fusion.  Genes marked with a * represent the mutant allele. 
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 4.4 Discussion 
 In agreement with these earlier studies (81, 125, 126), suggesting that the 
TatBC complex serves as the initial receptor binding site for precursor recognition, the 
genetic selection described herein has enabled the identification of two such putative 
regions in TatB and TatC that may be responsible for judging the folding character of 
Tat substrates, namely, residues 94-99 of TatC and 100-130 of TatB.  As both of these 
sites remain cytoplasmic and were heavily mutated among the best suppressors post-
selection, they serve as a great starting point for further investigation.  Consequently, 
it was entirely expected to find the MSR of two class I suppressors to reside within the 
TatBC proteins.  Furthermore, both of these suppressors harbor mutations in the 94-99 
gion of TatC, an area previously regarded as essential for Tat-mediated export, 
validating the integrity of our genetic selection. 
 However, our genetic selection was also able to produce an absolutely 
unexpected class I suppressor, namely mutant 66, possessing its MSR in the 
periplasmic domain of TatA.  While it remains undetermined, these twin-serines could 
teract with either the exported substrate at a later stage in translocation, i.e., after 
protein import system, the 
re
in
TatA has been recruited to the TatBC pre-complex, or the actual TatBC pre-complex 
itself.  Although it initially seems counterintuitive to the current working model of Tat 
recognition and export, the former scenario remains an open possibility supported by 
recent evidence of an apparent retrograde translocation mechanism in the plant 
thylakoid Tat system.  Specifically, using an in vivo tobacco protoplasts model, Di 
Cola and coworkers (144) demonstrated a late-stage, large-scale translocation reversal 
with both authentic and heterologous Tat substrates, whereby substrates were shown 
to be transported across the thylakoid membrane in a Tat-dependent manner, followed 
by a late-stage rejection after translocation had occurred and final localization back to 
the stromal side (since the Tat pathway in chloroplasts is a 
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 stromal compartment is equivalent to the bacterial cytoplasmic space, and the 
ard in that conformational changes 
chloroplast lumen is analogous to the bacterial periplasm).  These studies provide 
substantial evidence that recruitment of the intact multi-protein Tat complex does not 
necessarily result in unidirectional translocation, and thus, allows for the possibility of 
a late-stage quality control event to occur.  In other words, Tat proteins that are 
ultimately rejected by the translocation machinery have presumably interacted with a 
fully assembled TatABC translocon.  If an analogous late-stage retrograde 
translocation process occurs in the E. coli Tat system on a similarly large-scale, TatA 
could serve as a late-stage quality control checkpoint such that key mutations on the 
periplasmic side of TatA (e.g., mutant 66) could allow for the suppression of this 
quality control event after TatABC assembly has already occurred.  Nevertheless, the 
second alternative is much more straightforw
induced by the interaction of mutant TatA with TatB, TatC, or both could relax the 
intrinsic quality control mechanism of the TatBC components, allowing for the export 
of bound substrates.  Regardless of the mechanism, this observation that mutant 66 
possesses a MSR in TatA presents an amendment to the current Tat model of quality 
control and export.  Namely, that the intrinsic quality control feature of the Tat 
machinery is perhaps not an "on-off sensor," appraising folding fidelity in a single step 
prior to export, but rather, a more complex series of "security checkpoints" first 
screened at the TatBC pre-complex, and perhaps minimally, again after TatABC 
assembly. 
 In summary, the α3–TEM1 selection, developed in Chapter 3, has proven to be 
a robust tool for the isolation of mutant Tat translocases that retain their native export 
functionality while suppressing quality control.  This was demonstrated by their ability 
to tolerate both wild-type substrates and non-native substrates – a feat surpassing 
many earlier studies seeking the isolation of suppressor translocases.  Furthermore, we 
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 have isolated several distinct classes of suppressors, each harboring unique mutations 
responsible for suppression of quality control.  Insight gained from this selection has 
enabled the discovery of two precise regions on both TatB and TatC attributable to the 
strongest suppressor phenotype.  While the precise molecular mechanism of action 
remains elusive, the genetic elucidation of several key steps underlying this intrinsic 
folding quality control mechanism holds great promise for future discovery and offers 
a broad-range of engineering and biotechnological applications. 
 
4.5 Materials and methods 
4.5.1 Bacterial strains, plasmids, and growth conditions 
 Bacterial strains, plasmids and growth conditions used in this study are 
described in Chapter 3.3.1, unless otherwise mentioned.  In order to genetically dissect 
the suppressor mutants, the pTatABC template vector needed to be made modular.  
Enabling this feat was the addition of an in-frame XhoI restriction enzyme site 
flanking TatC at its 5'-end and a similar in-frame XbaI site at the 5'-end of TatB, 
resulting in the cloning vector, pTatABC-XX.  Each mutated suppressor gene was 
subsequently PCR amplified and backcloned into the pTatABC-XX cloning vector 
using the appropriate cutsites.  Below is a full list of all strains and plasmids used in 
this study.  All plasmids generated in this study were confirmed by sequencing. 
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  4.5.2 Spot plating and growth studies 
 Growth conditions and spot plating procedures used in this study are as 
described in Chapter 2.3.2, unless otherwise mentioned. 
 
4.5.3 Subcellular fractionation and Western blot analysis 
 The methods for protein analysis by subcellular fractionation and Western 
blotting that were used in this study are as described in Chapter 2.3.3, with two 
exceptions.  First, all substrates were prepared in an identical manner as described in 
Chapter 2.3.3, but fractionated after only ~2-4 hours at 30ºC.  Second, protein 
detection in this study was determined with the following primary antibodies:  rabbit 
polyclonal 1ºα-GroEL (Abcam) diluted 1:10,000, mouse monoclonal 1ºα-Flag M2-
HRP (Sigma-Aldrich) diluted 1:3,000, rabbit polyclonal 1ºα-GFP-HRP (Abcam) 
diluted 1:25,000, and rabbit polyclonal 1ºα-PhoA-HRP (Abcam) diluted 1:5,000. The 
only secondary antibody used in this study was goat α-rabbit-HRP (Promega) diluted 
1:2,500. 
 
4.5.4 BCIP experiments 
 DADE (ΔtatABCDE) cells containing pTorA-AP (38) (i.e., plasmid-encoded 
alkaline phosphotase, phoA, targeted to the Tat pathway via an N-terminal TorA signal 
sequence) and a pTatABC vector (i.e., wild-type, mut 51, mut 57, or mut 66) were 
grown overnight at 37oC in LB supplemented with 10 μg/ml tetracycline and 100 
μg/ml ampicillin.  Cells were subcultured the following day, plated at single colony 
resolution on LB-agar plates containing the appropriate antibiotics, 0.1 mM isopropyl-
β-D-thiogalactoside (IPTG), and 150μg/mL 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP) and grown overnight for approximately 18 hours as described elsewhere (117). 
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 a Zeiss 100x/1,30 Oil Plan-
EOFLUAR lens and a SPOT FLEX digital camera from Diagnostic Instruments, Inc. 
ith five microliters of live 
cteria
4.5.5 Optical and fluorescence microsc
 All  DADE (ΔtatABCDE) cells harboring a pTatABC plasmid were imaged 
using a Carl Zeiss Axioskop 40 optical microscope with
N
(Sterling Heights, MI). Microscope slides were prepared w
ba l cells from an overnight culture, sandwiched with a coverslip, and imaged 
using an oil-immersion technique at a magnification of 1000x.  Fluorescence 
microscopy was conducted in a similar fashion using the identical instrument 
supplemented with an EXFO X-Cite Series 120 lamp (Mississauga, Ontario) and a 
EGFP emission filter. 
 CHAPTER 5 
ns have been found, not everything regarding TatB function 
remains unidentified.  Most of the information that is known regarding the mechanism 
in which TatB functions stems from either truncation analyses (55) or cysteine-
scanning mutagenesis studies (145). 
 One early truncation study proposed that only the first 70 amino acids of the 
171 aa protein were absolutely essential for function, as determined by a sequential C-
terminal truncation analysis of 10 amino acids at a time (55).  More specifically, the 
function of each TatB mutant was determined based on its periplasmic trimethylamine 
N-oxide (TMAO) reductase activity as compared to a wild-type TatB strain.  
However, while truncations up to 100 amino acids from the C-terminus displayed 
activity above background, only TatB proteins lacking the final 30 amino acids from 
the C-terminus behaved in a manner that was almost indistinguishable from wild-type.  
Thus, in the context of this study, the term "essential" is rather loosely defined.  
Regardless of the precise location in which TatB function was impaired, TatB proteins 
lacking a progressively larger chunk of the C-terminus directly correlated with a 
progressively diminishing TMAO reductase activity (55).  Interestingly, the 
approximate location at which TatB was considered essential is immediately 
 
RATIONAL DESIGN OF A CLASS II TWIN-ARGININE TRANSLOCATION 
QUALITY CONTROL SUPPRESSOR 
  
5.0 Introduction 
 Many studies have sought to find inactivating amino acid substitutions in the 
TatB protein of the twin-arginine translocation pathway in an effort to determine the 
nature of sidechains essential for Tat-mediated export.  While very few, if any, single 
amino acid substitutio
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 downstream of the predicted α-h mbrane domain and the putative 
amphiphatic helical-like domain.  Only the C-terminal portion of TatB, which is 
lar
 With a similar s of TatB in order to 
better determine protein function, Maldonado and coworkers recently demonstrated 
ybrid system to determine that the so-called "membrane-extrinsic" 
omain
nstrated three separate structural roles:  1) the 
elical transme
gely regarded to form a random coil, was deemed unimportant for function. 
goal of fully characterizing the domain
the use of a two-h
d  of TatB, i.e., residues 22-100, was able to self-interact in a parallel fashion 
with similarly positioned TatB molecules (146).  Further, even severe truncations 
leaving only the first 55 residues were shown to still stably interact with TatC in 
complex. 
 Taken together, the above studies suggest that the N-terminal 100 residues of 
TatB are likely regarded as essential only from a purely structural viewpoint.  In 
particular, the N-terminus has demo
ability to self-interact with additional TatB molecules; 2) the integration into the 
cytoplasmic bilipid membrane by its predicted N-terminal α-helix; and 3) the 
association with TatC in the form of the TatBC complex.  This in turn implies that the 
N-terminal domains could be responsible for the overall stability of the early TatBC 
complex, while the C-terminus could be involved in another aspect of export, such as 
quality control.  The behavior of key residues in the C-terminus of TatB that could be 
involved in folding quality control will be investigated in this chapter. 
 
5.1 Rational design of a class II suppressor 
 A major victory in any genetic selection is to not only isolate a desired protein, 
or protein complex, but to also glean information about the underlying basic science 
involved.  To this end, we sought to rationally design a suppressor of Tat-mediated 
quality control based on our observations and analysis of the mutations present in the 
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 class I suppressors.  It became increasingly apparent that the majority of the mutations 
in tatB formed a cluster similar to that of tatC, albeit more sparsely distributed than 
those in tatC.  In particular, the region from approximately residue 100 to 130, 
ntainco ed more than twice the number of mutations than any other region of 
comparable length, as shown below with the mutations from the best ten suppressors 
overlaid at their approximate location on a TatB topology map (Figure 5.1). 
 
 
 
Figure 5.1 Schematic of TatB mutations from the best ten suppressors overlaid 
ological structure of TatB as determined 
mutations are localized to the cytoplasmic domain, and more specifically, to the C-
on a TatB topology map.  The predicted top
by computational predictions from Lee et al. (55) was used to approximate the 
location of each TatB mutation pulled from the genetic selection.  As depicted above, 
the bacterial cytoplasmic membrane is represented by the uniformly shaded gray bar, 
with the cytoplasmic space shown below and the periplasmic space shown above.  
Consistent with the hypothesis of Tat-mediated quality control, the majority of 
terminal half of TatB. 
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  In this region of TatB, there are three histidine residues that stood out for a 
variety of reasons.  First, there are only seven histidines in the entire tatABC operon 
and three within a 14 amino acid stretch of the TatB protein alone.  Second, there are 
an abundance of serine (or threonine) residues in this area of TatB, as well as in the 
cytoplasmic loops of TatC, and even more of these same mutations found in many of 
the class I suppressors.  And perhaps most interesting is the observation that two of the 
ines in TatB are spaced exactly 14 amino acids apart, each of which, are in turn 
flanked by a serine residue also spaced at a distance of 14 amino acids.  Although the 
crystal structure remains unsolved, if this region were to at least form a transient alpha 
helix, it would form two serine-histidine pairs on the same side of a helical turn at 
exactly the n and n+2 positions. 
 Stemming from these observations we made the following hypothesis:  the 
imidazole side chains of the histidine residues found in the Tat proteins are, at a 
minimum, partly responsible for the strongest quality control suppressing phenotype.  
In order to test this hypothesis, a rationally designed, site-directed mutant was created 
by systematically replacing one, two and three of the TatB histidine residues with 
alanine residues (Figure 5.2a).  Interestingly, with only a single histidine-to-alanine 
mutation, i.e., H123A, the mutant translocase was capable of suppressing the α3B– 
TEM1 fusion and its more well-ordered counterparts.  Furthermore, and most 
importantly, upon replacing all three histidine residues with alanines, the 
TatBH109A/H113A/H123A mutant translocase suppressed the full panel of α –TEM1 fusions 
histid
3
up to an ampicillin concentration of 300 μg/mL (Figure 5.2b). 
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Figure 5.2 TatB histidine mutants result in class II suppression.  (a)  The tatB gene 
from residues 90 to 140, displaying the histidine and serine residues spaced exactly 14 
amino acids apart.  (b) Growth analysis of the site-directed H-to-A mutant translocases 
on LB-agar plates containing 300 μg/mL ampicillin.  All cells are a DADE 
(ΔtatABCDE) strain background, harboring a pTatABC-Mutant translocase vector and 
a pSALect–ssTorA–α3–TEM1 vector, as indicated.  Five microliters of cells were 
spotted after ten-fold serial dilutions.  (c & d) Microscopy and Western blot analysis 
of native and non-native substrates performed as described earlier. 
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  In a similar fashion to the class I suppressors, the TatBH109A/H113A/H123A mutant 
translocase was characterized by its ability to export both native Tat substrates (AmiA, 
AmiC, CueO, and SufI), and non-native Tat substrates (ssTorA-GFP and ssTorA-
PhoA).  While the TatBH109A/H113A/H123A mutant translocase complemented the chain-
like phenotype characteristic of DADE (ΔtatABCDE) cells and exported the native Tat 
substrates with equal facility as a wild-type translocase (Figure 5.2c), it was only 
partially permissive with the non-native Tat substrates (Figure 5.2d).  In particular, 
ssTorA-GFP was very well tolerated and exported in a folded confirmation 
sequestered to the poles of the cell as evidenced by fluorescence microscopy.  
Moreover, immunoblotting of the subcellular fractions revealed ssTorA-GFP present 
in the periplasm at a level on par with the wild-type translocase.  However, the 
defining feature of a class I suppressor is its ability to export ssTorA-PhoA in a folded 
and functional state and the TatBH109A/H113A/H123A mutant translocase failed this final 
test, resulting in the classification as a class II suppressor. 
 
5.2 Discussion 
 In addition to the interesting location of many of these mutated residues, the 
identity of the actual residue is also quite remarkable.  Histidines, serines, and 
aspartates are well known to interact with each other as part of a catalytic triad found 
in many serine proteases, such as trypsin, subtilisin, and acetylcholinesterase (147).  
However, it is unlikely that the abundance of serine (and threonine) mutations pulled 
from the genetic selection described in previous chapters, along with the rationally-
designed histidine mutant described in this chapter, are acting in a catalytic manner to 
suppress quality control.  Nevertheless, given their sheer abundance, the reactive 
hydroxyl sidechain chemistry of serine and threonine residues is likely a contributing 
factor in the overall suppressing phenotype. 
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  Alternatively, histidines have also been shown to play essential roles in the 
activity of certain chaperones, such as calreticulin, a Ca+2-binding chaperone found in 
the lumen of the endoplasmic reticulum (148).  This latter example is particularly 
attractive due to the nature of the Tat machinery.  In particular, as it was originally 
hypothesized in the seminal work of Tat-mediated quality control (38), a cytoplasmic 
domain of one or more Tat membrane proteins could function as a chaperone in its 
ability to identify folded substrates.  Furthermore, Guo et al. suggest a possible 
mechanism of action for the essential histidine of calreticulin attributing its function as 
a chaperone to either the structural changes induced by the absence of the histidine 
residue or the inability of the histidine to bind zinc ions necessary for function (148).  
This is a particularly insightful observation because the majority of Tat substrates 
require the addition of a metal cofactor.  Therefore, it is certainly plausible that the 
flexible cytoplasmic tail of TatB could act as a probe for metal cofactor addition 
enabled by the metal chelating ability of its histidine residues. 
In this chapter, we have demonstrated the ability to rationally design a class II 
lding quality control based on our observations gleaned from the best 
ibed in Chapter 3. 
 
suppressor of fo
suppressors described in the previous chapters.  This site-directed mutant, harboring 
three histidine mutations in the tatB gene, was able to weakly export the molten 
globular α3 proteins as demonstrated by growth out to a dilution factor of 10-6 on 
300μg/mL of ampicillin.  This concentration of ampicillin was significantly higher 
than that of a wild-type translocase, but much lower than that of the best suppressors.  
Furthermore, the TatBH109A/H113A/H123A mutant translocase was capable of exporting the 
less cumbersome substrates, CueO, SufI and ssTorA-GFP, but remained unable to 
transport the archetypal class I substrate, ssTorA-PhoA and thus, was classified as a 
class II suppressor.  Nevertheless, the ability to create such a mutant is an amazing feat 
and a testament to the genetic selection descr
56 
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 in this study are as 
5.3 Materials and methods 
5.3.1 Bacterial strains, plasmids, and growth conditions 
 Bacterial strains, plasmids and growth conditions used in this study are 
described in Chapter 3.3.1 and Chapter 4.5.1, unless otherwise mentioned. 
 
5.3.2 Site-directed mutagenesis of tatB 
 The three histidine mutants were constructed using the QuikChange® II site-
directed mutagenesis kit (Stratagene), whereby the native codons, CAC or CAT, 
encoding histidine residues were site-specifically mutated to the GCG codon, resulting 
in alanine residues.  All mutants were generated in a wild-type pTatABC vector and 
sequenced for confirmation. 
 
5.3.3 Spot plating and growth studies 
 Growth conditions and spot plating procedures used
described in Chapter 2.3.2, unless otherwise mentioned. 
 
5.3.4 Subcellular fractionation and Western blot analysis 
 The methods for protein analysis by subcellular fractionation and Western 
blotting that were used in this study are as described in Chapter 2.3.3 and Chapter 
4.4.3, unless otherwise mentioned. 
 
5.3.5 Optical and fluorescence microscopy 
 All optical and fluorescence microscopy was performed exactly as described in 
Chapter 4.5.5, unless otherwise mentioned. 
 CHAPTER 6 
PO
 
combinant proteins that has garnered much interest in the 
iotechnology and pharmaceutical fields is the single-chain variable fragment 
t antibody molecules represent a substantial 
ster ovary (CHO) cell lines, 
hich are much more delicate and expensive to maintain than bacterial hosts.   Despite 
otein must be produced in 
ul production of these proteins largely depends on 
xporting them into the periplasmic space (152).  However, while export of these 
ment for folding, the quantity of protein 
 Therefore, many attempts have been made to improve the yield of recombinant 
antibody fragments in E. coli, e.g., refolding protein from inclusion bodies (154), 
 
SSIBLE BIOTECHNOLOGICAL APPLICATIONS OF MUTANT TWIN-
ARGININE TRANSLOCATION LIBRARIES 
6.0 Introduction 
 Cost-effective biological hosts, such as gram negative bacteria, and especially 
E. coli, have long been used in the field of biotechnology to produce valuable 
recombinant proteins due to a variety of factors including:  fast doubling times, ease of 
manipulation, high cellular densities, and simple protein purification techniques (149).  
One such class of valuable re
b
antibody (scFv).  These recombinan
portion of proteins undergoing clinical trials (150).  However, current production 
schemes generally involve purification from Chinese ham
w
these shortcomings, very large quantities of recombinant pr
order to be useful, and generally, this need far exceeds the ability of E. coli (151).  
Furthermore, scFv molecules normally require the formation of disulfide bonds in 
order to function, and thus, successf
e
proteins provides a more conducive environ
exported is limited by the export process and is generally no more than 10% of the 
total soluble yield (153). 
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 toggling the redox conditions of th ), and re-engineering the protein 
fold to become stable within the cytoplasm (155), precluding disulphide bond 
form hey 
generally require ex ng each individual 
substrate is greatly increased.  Thus, a univ rsal means for isolating large quantities of 
binant scFvs by standard protein purification methods would serve 
tant translocases that transport into the periplasm increased 
mount
e cytoplasm (38
ation.  While many of these methods have achieved some degree of success, t
tensive work, and therefore, the cost for improvi
e
high purity recom
as a vast improvement to the current methods and reduce the overall cost of producing 
many promising therapeutic targets that may otherwise never see the clinic. 
 To this end, we have screened a mutant tatABC library against a highly soluble 
scFv target in order to obtain broad-spectrum hypersecreting translocases that may 
help relieve the bottleneck associated with protein export and foster the discovery of 
novel therapeutics. 
 
6.1 Isolation of hypersecreting Tat translocases that preserve quality control 
 While the isolation of suppressor translocases has proven to be invaluable in 
the identification of specific residues and particular regions of the Tat machinery 
proteins responsible for quality control at a basic science level, the true utility of the 
studies discussed in this body of work is the ability to exploit this knowledge to 
produce something of interest to the greater scientific community.  To this end, we 
have developed the following hypothesis:  if the Tat machinery is indeed an integral 
part of export quality control, it should be possible to isolate mutant translocases 
capable of hypersecreting valuable protein substrates while maintaining an intact 
quality control  system.  In other words, our next goal was to generate a completely 
new and unique set of mu
a s of substrates possessing a common fold, instead of mutant translocases that 
suppress folding quality control.   
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  To ensure that the diversity of the library was large enough to isolate 
meaningful clones, we took advantage of the identical tatABC library of ~5.5 x 106 
members as described in Chapter 3.   Previously, we used a particularly poorly folded 
substrate to select for mutant translocases that would necessitate the relaxation of the 
Tat machinery's intrinsic quality control mechanism in order for cells to remain viable 
on selective medium.  Conversely, in an effort to avoid selection of suppressors, here 
we chose to use a very well-ordered protein substrate, facilitating the selection of 
hypersecreting variants.  In particular, we chose to use the single chain variable 
agme
t, β-galactosidase.   Not only is this a very well-folded substrate, 
Fvs in general, are of similar size, shape, and fold.  Thus, if our hypothesis held true, 
able of 
idual clones were picked and counter-screened at a 
fr nt, scFv-R4.  This antibody fragment was created by Martineau and coworkers 
(152, 155) through a rigorous four-round directed evolution strategy, culminating in 
the production of a very well-folded, highly soluble antibody fragment with great 
affinity for its targe
sc
it is theoretically possible that each hypersecreting variant would be cap
exporting many different scFvs with similar faculty – a feat which holds immense 
potential for the pharmaceutical and biotechnology fields. 
 In a similar fashion as described in Chapter 3.1, prior to library selection cells 
harboring a wild-type Tat translocase and the pSALect–ssTorA–scFvR4–TEM1 
partner plasmid were spotted onto a series of ampicillin concentrations in order to 
determine the appropriate selection conditions, i.e., a cellular dilution and ampicillin 
concentration that resulted in very little growth.  This was determined to be 300μg/mL 
ampicillin and a cellular dilution factor of 10-3 from an overnight culture. Once these 
appropriate selection conditions were determined, DADE (ΔtatABCDE) cells 
containing the pSALect–ssTorA–scFvR4–TEM1 partner plasmid were transformed 
with the freshly midiprepped tatABC plasmid library and directly selected on 
ampicillin containing plates.  Indiv
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 ce  dilution of 10-3 on LB-agar plates supplemented with 300μg/mL ampicillin, 
respectively, to rank-order and isolate only those clones which grew better than those 
cells harboring a wild-type Tat translocase.  As expected, there was a variety of 
growth phenotypes, ranging from those that did not grow at these levels and those that 
grew rather well (Figure 6.1). 
 
llular
 
 
Figure 6.1 Counter-screen for hypersecreting variants reveals many potential 
candidates.  Five microliters of cells from an overnight culture were diluted by a 
factor of 10-3, spotted onto LB-agar plates supplemented with 300 μg/mL of ampicillin 
and growth overnight at 30ºC. 
 
 The best three growers were isolated, cured of the pSALect–ssTorA–scFvR4–
TEM1 partner plasmid, backtransformed into fresh DADE (ΔtatABCDE) cells 
harboring the pSALect–ssTorA–scFvR4–TEM1 vector to ensure that this improved 
growth phenotype was a result of the mutant translocase and not a mutation elsewhere 
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 in the genome.  Indeed, upon spotting these top three mutants on a series of ampicillin 
concentrations at every cellular dilution up to 10-8, all mutant Tat translocases 
conferred a marked increase in resistance to ampicillin as determined by cellular 
growth in relation to a wild-type Tat translocase (Figure 6.2). 
 
 
 
Figure 6.2 Demonstration of improved growth on ampicillin containing plates.  
Each hypersecreting variant was grown overnight at 37ºC and serial diluted the 
following day by factors of ten in a 96-well tissue culture plate.  Five microliters of 
cells were spotted onto LB-agar plates containing 25 μg/mL chloramphenicol and 10 
μg/mL tetracycline (left) or 300μg/mL ampicillin (right) and grown overnight at 30ºC. 
   
These three hypersecreting variants were sequenced to determine the identity of the 
mutations responsible for this marked increased in growth on ampicillin (Table 6.1). 
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6.2 Discussion 
 Here we have shown a promising novel use of great engineering value for the 
genetic selection developed in Chapter 3 to investigate Tat translocases.  Importantly, 
the system has been designed in a modular fashion in order to facilitate the selection of 
hypersecretors of any substrate protein, demonstrating its promise as a widespread tool 
for improving the folded, periplasmic yields of valuable target proteins. 
 A potential drawback of the technology described herein would be that in the 
process of creating a hypersecreting variant, one might also isolate a clone with a 
relaxed quality control mechanism, thereby eliminating the benefit of using the Tat 
pathway in the first place (i.e., exploiting its innate ability to export only fully folded, 
native proteins into the periplasm as a cellular pre-screen of folding quality).  
terminal half of TatB almost entirely.  Moreover, there is only a single mutation in the 
r 
.3 and determined to have no effect on quality control as evidenced by a wild-type 
growth phenotype of the α3s on ampicillin.  Thus, at least in these preliminary 
However, interestingly, the mutations we have observed thus far, suggest otherwise.  
In particular, the best three hypersecreting variants isolated in this proof-of-principle 
study all lack mutations in the 94-99 range of TatC and avoid mutation of the C-
hypersecreting lot that overlaps with those isolated as suppressors, namely, I183T in 
TatC.  Interestingly, this mutation was also one of those carefully dissected in Chapte
4
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 experiments, it is unlikely that Tat hypersecretors will also possess suppressor 
capabilities. 
 Another interesting observation among the hypersecretors is a dearth of 
cytoplasmic mutations, and instead, an abundance of hydrophobic residues within the 
transmembrane domains changed into methionine residues.  A cursory glance would 
suggest that these are completely innocuous mutations; however, given the dynamics
f protein export, and in particular, Tat export, these could be involved in a much 
way.  The majority of these mutations are leucine-to-methionine or 
especially in 
 
o
more dominant 
valine-to-methionine, and thus, are long, unbranched sidechain replacements.  In other 
words, the ability of these residues to tightly pack within the transmembrane domains 
may be greatly disrupted, or minimally, alter the wild-type conformation within these 
regions.  Moreover, it has been demonstrated that leucine-to-methionine substitutions 
can have a rather drastic destabilization effect on protein stability, 
regions which lack solvent exposure (156), as would be the case with these 
transmembrane helices.  Interestingly, the Tat export model gaining in popularity 
suggests that TatA homo-oligomers are responsible for destabilizing the membrane in 
the local proximity of the TatBC-substrate complex (68).  Therefore, it is plausible 
that these methionine mutations found in transmembrane regions of the best 
hypersecretors result in the disruption of packing in the local micro-environment of 
Tat-substrate complexes, allowing for substrates to pass through the delicate 
membrane and into the periplasm.   Further substantiating these claims are the recent 
observations by Lee and coworkers, demonstrating that the extreme N-terminus of 
TatB, as part of the TatBC complex, self-interacts within the membrane in such a way 
as to allow the possibility of membrane destabilizing mutations (145).  Furthermore, 
the highly conserved glutamate residue at position 8 within this membrane domain has 
been implicated in linking proton movements to the transport process (57, 157), and 
64 
 thus, certainly could be a candidate for hypersecreting activation.  Most strikingly, two 
of the best hypersecreting variants isolated in this study have mutations in this area.  
Specifically, HyV-1, directly replaces this acidic glutamate with a basic lysine, which 
could have drastic effects on the hydrogen-bonding capabilities at this position within 
the transmembrane helix; and HyV-9, has a leucine-to-proline mutation one residue 
removed from Glu-8, which could have an equally membrane destabilizing effect due 
to the propensity of proline residues to form kinks in helices. 
 Taken together, the above results suggest that the hypersecreting variants 
indeed form a separate unique set of mutant Tat translocases responsible for 
hypersecreting their substrate protein, and not, merely suppressing quality control.  
Thus, by simply comparing the mutations found in any future hypersecreting variants 
with the list of mutant suppressors described in Chapter 4.3, one could eliminate any 
translocases which simultaneously hypersecrete substrate protein and suppress quality 
control.  Moreover, the α3 family of proteins could be used as a further screen for 
translocases, confirming that they continue to behave like wild-type in their ability to 
reject transport-incompetent substrates, while only hypersecreting fully folded 
substrates. 
 Therefore, in order to isolate hypersecretors it is recommended that one use a 
very well-ordered substrate to circumvent the need for suppression of the quality 
control mechanism.  While quality control is likely to always be engaged, it is also 
likely that well-folded substrates spend less residence time at the machinery as 
compared to poorly folded substrates, and therefore, interact less with the machinery 
itself due the expeditious clearance through quality control.  Conversely, poorly folded 
substrates are likely to dwell at the machinery, interact more with it, and ultimately 
fail to pass through quality control.  Thus, while the strategy described herein remains 
a valid tool for isolating hypersecretors of any substrate protein, the best results will 
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 likely occur when a well-ordered protein is used as the substrate.  Furthermore, the 
most precious variants will likely be those hypersecreting valuable substrates of a 
common fold, such as the scFvs used in the proof-of-principle study described above, 
or cellulases – proteins heavily sought after for their potential use in generating 
renewable biofuels (158).  Nonetheless, as demonstrated above the use of mutant 
tatABC libraries and robust genetic selections contained in this body of work hold 
great promise for many downstream biotechnological applications. 
 
6.3 Materials and methods 
6.3.1 Bacterial strains, plasmids, and growth conditions 
 Bacterial strains, plasmids and growth conditions used in this study are 
described in Chapter 3.3.1, unless otherwise mentioned.  Below is a full list of all 
strains and plasmids used in this study.  All plasmids generated in this study were 
confirmed by sequencing. 
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 6.3.2 Spot plating and growth studies 
 Growth conditions and spot plating procedures used in this study are as 
described in Chapter 2.3.2, unless otherwise mentioned. 
 
6.3.3 Library construction and selection 
 The library used for the isolation of hypersecreting variants was the identical 
randomly mutated tatABC library as described in Chapter 3.3.2, unless otherwise 
entioned. m
 
6.3.4 Plasmid curing and isolation of mutant tat vectors 
 The pSALect–ssTorA–scFvR4–TEM1 plasmid was cured from each clone in 
order to isolate individual mutant tatABC plasmids as described in Chapter 3.3.3, 
unless otherwise mentioned. 
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 CHAPTER 7 
 TRANSLOCATION 
SUPPRESSORS OF FOLDING QUALITY CONTROL 
  
escribed in detail in Chapter 4, holds great promise for the further 
lucidation of Tat-mediated export and intrinsic quality control.  Within the previous 
nt translocases in order to 
tive studies. 
 By comparison, over three decades ago elegant genetic strategies comparable 
to those described herein, were implemented to discover a series of protein 
localization mutants, termed prl suppressors (159, 160).  These prl mutants were first 
isolated by their ability to export Sec substrates harboring defective signal peptides.  
Since little was known about the general secretory pathway at the time, these initial 
studies aimed to identify the gene products responsible for suppression through fine 
structure gene mapping.  As might be expected, there were a variety of suppressors 
corresponding to three different genetic loci, termed prlA through prlC, with some 
suppressor phenotypes stronger than others (159, 160).  Nevertheless, the ability to 
link genotype to phenotype provides strong evidence that the underlying molecular 
mechanisms were indeed a direct consequence of the genetic mutants found.  Many 
studies later, the strongest of these Sec suppressors, prlA, was eventually determined 
to be a component of the inner-membrane general secretory apparatus, namely SecY 
 
FUTURE DIRECTIONS OF TWIN-ARGININE
7.0 Introduction 
 The identification of strong Tat suppressors of folding quality control, i.e., the 
class I suppressors d
e
chapters we have painstakingly characterized these muta
confirm their authenticity; however, despite the wealth of information that we have 
already gained from these initial experiments, there still remains more that can be 
learned from such transforma
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 (161-163).  In the context of our Tat suppressors of folding quality control, the true 
merit of these studies is that it took the isolation of Sec suppressor mutants to initiate 
the furt export 
(164-167). 
 Consequently, we would be rem ss if we failed to acknowledge the 
llels our class I suppressors of the Tat pathway have with the prl 
. 
her elucidation of the molecular mechanics of Sec-mediated protein 
i
considerable para
mutants of the Sec pathway.  With the isolation of these Tat suppressors of folding 
quality control, it is our sincere desire that further analysis of our most promising 
mutants will reveal important mechanistic details about Tat-mediated export in a 
similar fashion as the prl suppressor mutants have done for the Sec pathway.  Several 
exciting avenues that can be immediately explored are outlined in the following 
experiments with the hope of sparking a new understanding of the export of folded 
proteins across the cytoplasmic membrane
 
7.1 Specificity of quality control suppression 
 An important question asked early on in the selection process was:  have we 
abolished all forms of quality control, such that every substrate is exported with little 
regard to specificity?  The reason this becomes so important is that ultimately we 
sought to create a genetic selection which suppresses folding quality control, and thus, 
acts as a judge of the folding character alone.  If every last substrate is exported 
regardless of the extent of misfolding, the genetic selection speaks very little to the 
underlying mechanism of suppression.  To this end, we began probing substrate 
specificity by substituting defective signal peptides into the α3 substrates using site-
directed mutagenesis, whereby the characteristic twin-arginine residues were site-
specifically mutated to either twin-lysines or a lysine-glutamine pair.  It is well-
documented that replacement of the near invariant twin-arginines with either twin-
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 lysines or a lysine-glutamine pair, completely blocks export via the Tat pathway.  As 
such, regardless of the folding character of the α3 protein, in theory, even a well-
ordered variant harboring one of these defective signal peptides should not be 
exported, and thus, cells should not grow on ampicillin containing plates.  Indeed, all 
ss I cla suppressing translocases could not overcome either defective signal sequence 
as demonstrated by a substantially hindered growth pattern on ampicillin (Figure 7.1).   
 
 
 
Figure 7.1 Class I suppressors retain the ability to recognize defective Tat signal 
sequences.  All cells in this study were a DADE (ΔtatABCDE) strain background 
harboring a wild-type (WT), or mutant copy, of the pTatABC plasmid and one of the 
pSALect–ssTorA(KK/KQ)–α3–TEM1 plasmids, as indicated.  Each class I suppressor 
μg/mL chloramphenicol (positive growth control) or 300 μg/mL ampicillin containing 
plates, and incubated overnight at 30ºC.  All translocases, including wild-type and 
each class I suppressor, lacked growth on ampicillin containing plates, indicative of an 
ability to recognize defective Tat signal peptides. 
 
 Retained ability to reject substrates lacking appropriate signal sequences 
confirms that each class I suppressor is truly judging folding character alone, and not, 
globally abolishing general quality control – further validation that the Tat machinery 
was serial diluted by factors of ten, spotted onto either 10 μg/mL tetracycline + 25 
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 proteins themselves indeed possess an intrinsic mechanism of folding quality control.  
In other words, it is likely that the suppressors described within this body of work are 
genuine suppressors of folding character and not completely relaxed bystanders in the 
translocation process such that they have become a passive channel for export.  
Nevertheless, an important follow-on to this question would be: what is the exact 
degree of substrate specificity achieved by these suppressors? 
 Apart from signal peptide recognition, another key element of Tat-mediated 
translocation is the export of cofactor-containing substrates.  As previously mentioned, 
Tat substrates requiring proper cofactor insertion prior to export, such as NrfC and 
NapG, have been shown be to targeted for degradation when their cofactor clusters 
have been misassembled (84).  Thus, a logical next question would be: can the class I 
suppressors isolated herein export these misassembled cofactor-containing Tat 
substrates?  It is difficult to predict whether the class I suppressors would be able to 
accomplish this feat, as cofactor insertion is directly related to the protein fold; 
however, the degree of "misfolding" due to misassembly is not necessarily equivalent 
to "unfolded."  Therefore, a series of experiments targeting the degree in which these 
suppressors are capable of probing cofactor assembly would help clarify the extent of
pression 
 
suppression specificity.  Moreover, if the class I suppressors are unable to export 
cofactor-misassembled substrates, the identical mutant tatABC library constructed in 
Chapter 3 could once again be used in order to isolate suppressors that allow export of 
these misassembled substrates. 
 
7.2 Structural determinants of quality control sup
 While many of the studies described throughout the previous chapters have 
focused on determining a mechanism of action based on residue substitutions and the 
biochemical implications these may have on the substrate-machinery interaction, an 
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 equally interesting notion pertains to interactions among machinery components 
themselves.  Numerous studies have isolated Tat complexes of varying compositions 
with a molecular mass as large as approximately 600kDa in size, implying that the 
active translocon must contain multiple copies of each Tat protein (66, 168, 169).  
Furthermore, it has been demonstrated that the formation of a functional complex is 
intimately dependent upon a precise stoichiometry of the Tat proteins (170-172).  
isfolded substrates 
To date, the research conducted herein has solely focused on protein folding 
ng a functional protein; 
Consequently, these studies have resulted in the development of robust methods for 
analyzing the molecular assembly and interactions between them.   As such, a wealth 
of information could be  gained from future experiments examining the perturbations 
that suppressors have on this stoichiometry and the implications these may have on the 
structure of complex formation.  Furthermore, molecular visualization tools, such as 
the bimolecular fluorescence complementation (BiFC) technology developed to 
interrogate the molecular interactions along the Tat pathway (173), could be harnessed 
to study the specific contacts that each class of suppressor translocase makes with its 
substrates, as well as among the Tat components themselves.  Structural determinants, 
whether they are based on differences in molar ratios among the Tat proteins in 
complex, interactions with each other in the context of substrate translocation, or 
something else altogether, could help further elucidate the precise molecular details of 
folding quality control, and more importantly, the suppression thereof. 
 
7.3 Tat-specific proteolysis of m
 
quality control, that is, the productive process of creati
however, as mentioned in Chapter 1, the inverse of protein folding, i.e., protein 
misfolding, also necessitates a form of quality control.  The destructive process of 
protein degradation ultimately serves a constructive function to rid the cell of unusable 
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 products and help alleviate the cellular stress associated with protein production, and 
thus, this proteolysis is a very important final form of protein folding quality control.  
Due to the uniqueness of the Tat pathway, the degradation of misfolded protein along 
the Tat pathway has the potential to be similarly special.  In particular, if export of Tat 
substrates is mediated by an entire set of Tat-specific chaperones and machinery 
components, completely independent of those present in the Sec pathway, then it is a 
logical question to ask whether there also exists unique Tat-specific degradation 
machinery.  One hypothesis recently suggested that TatD, a component of the Tat 
pathway long thought to serve little to no function in Tat-mediated export (123), may 
be involved in the rapid turnover of misfolded substrates to cellular proteases (174).  
However, shortly after publication the article was rescinded and its findings resolved 
to be the mere artifact of substrate overexpression levels as a consequence of inducer 
choice (175). 
 Nevertheless, the underlying question remains unanswered – what cellular 
components are responsible for the rapid degradation of misfolded, misassembled Tat 
substrates?  Is it a Tat specific-protease, or a general cytoplasmic housekeeping 
mechanism?  This intriguing aspect of folding quality control remains largely 
unexplored, and thus, studies aimed at shedding light on the black box that is Tat-
mediated protein degradation of misfolded substrates promises to be a very rewarding 
ndeavor. e
 
7.4 Materials and methods 
7.4.1 Bacterial strains, plasmids, and growth conditions 
 Bacterial strains, plasmids and growth conditions used in this study are 
described in Chapter 3.3.1 and Chapter 4.5.1, unless otherwise mentioned. 
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7.4.2 Site-directed mutagenesis of Tat signal sequences 
 The defective signal peptides used in this study were constructed using the 
QuikChange® II site-directed mutagenesis kit (Stratagene), whereby the native 
codons, CGT and CGG, encoding arginine residues were site-specifically mutated to 
the AAG AAG codons, or the AAG CAG codons, resulting in twin-lysines or a lysine-
glutamine pair, respectively.  All mutants were generated in a wild-type pTatABC 
vector and sequenced for confirmation. 
 
7.4.3 Spot plating and growth studies 
 Growth conditions and spot plating procedures used in this study are as 
described in Chapter 2.3.2, unless otherwise mentioned. 
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